###begin article-title 0
###xml 83 89 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 77 82 <span type="species:ncbi:9606">human</span>
Development of an isoform-specific gene suppression system: the study of the human Pax-5B transcriptional element
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 440 445 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 458 464 458 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 621 627 621 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 710 716 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 793 798 793 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 819 827 819 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 955 961 955 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 996 1000 996 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1063 1069 1063 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1205 1211 1205 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 530 533 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 615 620 <span type="species:ncbi:9606">human</span>
The transcription factor Pax-5, is vital during B lymphocyte differentiation and is known to contribute to the oncogenesis of certain cancers. The Pax-5 locus generates multiple yet structurally related mRNA transcripts through the specific activation of alternative promoter regions and/or alternative splicing events which poses challenges in the study of specific isoform function. In this study, we investigated the function of a major Pax-5 transcript, Pax-5B using an enhanced version of the Hepatitis Delta Virus ribozyme (HDV Rz) suppression system that is specifically designed to recognize and cleave the human Pax-5B mRNA. The activity of these ribozymes resulted in the specific suppression of the Pax-5B transcripts without altering the transcript levels of other closely related Pax-5 isoforms mRNAs both in vitro and in an intracellular setting. Following stable transfection of the ribozymes into a model B cell line (REH), we showed that Pax-5B suppression led to an increase of CD19 mRNA and cell surface protein expression. In response to this Pax-5B specific deregulation, a marked increase in apoptotic activity compared to control cell lines was observed. These results suggest that Pax-5B has distinct roles in physiological processes in cell fate events during lymphocyte development.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 300 303 300 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 416 417 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 418 419 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 668 673 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 755 756 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 761 766 761 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 951 956 951 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 1090 1094 1090 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1107 1108 1107 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1109 1110 1109 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1113 1118 1113 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 1317 1318 1317 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1319 1321 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
Recent studies have demonstrated that the Pax gene family controls gene expression activity at the transcription level and regulates fundamental cellular processes such as proliferation, differentiation and cell death events (apoptosis) (1,2). Given their essential role in cell biology, deregulated Pax genes also act as oncogenes and have the potential to transform normal cells into their cancerous counterparts (2,3). A well-studied member of this family, Pax-5, is known to encode the B-cell specific activator protein (BSAP) which is expressed in the embryonic central nervous system, B lymphocytes, and adult testis (4). In the past decade, the interest in the Pax-5 transcription factor has been drawn to its pivotal role in B-cell lymphogenesis (5,6). Pax-5 requirement to B commitment is highlighted by its transcriptional control over key events that are essential for B-cell development and activation. Studies have identified a number of Pax-5 target genes several of which are known to modulate the expression of B-cell receptor (BCR) components and associated proteins (i.e. CD19, blk etc.) (7,8). Pax-5 selective pressure to B-cell commitment is also conveyed by its ability to negatively regulate non-conforming pathways of the B lineage leading to the differentiation of non-B cellular development (9,10).
###end p 4
###begin p 5
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 571 577 571 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 582 588 582 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 677 685 677 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 689 698 689 698 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 731 734 731 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 763 764 763 764 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 776 781 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 1110 1111 1110 1111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1270 1273 1270 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1274 1276 1274 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1555 1557 1555 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1558 1560 1558 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 698 1562 698 1562 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="6">Schematic structure of the human <italic>Pax</italic>-<italic>5</italic> gene and the SOFA-HDV Rz (<bold>A</bold>) The human <italic>Pax-5</italic> gene located on chromosome 9 includes two alternative promoter regions (empty boxes\promoters A and B) which regulate the expression of exclusive exon regions (solid boxes) 1A and B, respectively, followed a common exons 2&#8211;10 sequence. The dotted diagonal lines indicate the spliced regions from the mature coding transcripts. (<bold>B</bold>) The structure of the SOFA-HDV Rz adopts an off (left panel) and locked configuration secured by the blocker stem in the absence of its specific mRNA target (<italic>Pax</italic>-<italic>5B</italic>). In the presence of the specific substrate (right panel) the SOFA-HDV Rz adopts a catalytically active configuration which is formed through the annealing of the ribozyme's biosensor (BS) and P1 stem (P1) to the target substrate. These structures were previously described in (<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>).</p>
###xml 698 1562 698 1562 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="6">Schematic structure of the human <italic>Pax</italic>-<italic>5</italic> gene and the SOFA-HDV Rz (<bold>A</bold>) The human <italic>Pax-5</italic> gene located on chromosome 9 includes two alternative promoter regions (empty boxes\promoters A and B) which regulate the expression of exclusive exon regions (solid boxes) 1A and B, respectively, followed a common exons 2&#8211;10 sequence. The dotted diagonal lines indicate the spliced regions from the mature coding transcripts. (<bold>B</bold>) The structure of the SOFA-HDV Rz adopts an off (left panel) and locked configuration secured by the blocker stem in the absence of its specific mRNA target (<italic>Pax</italic>-<italic>5B</italic>). In the presence of the specific substrate (right panel) the SOFA-HDV Rz adopts a catalytically active configuration which is formed through the annealing of the ribozyme's biosensor (BS) and P1 stem (P1) to the target substrate. These structures were previously described in (<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>).</p></caption>
###xml 1562 1562 1562 1562 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn432f1"/>
###xml 689 1562 689 1562 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="6">Schematic structure of the human <italic>Pax</italic>-<italic>5</italic> gene and the SOFA-HDV Rz (<bold>A</bold>) The human <italic>Pax-5</italic> gene located on chromosome 9 includes two alternative promoter regions (empty boxes\promoters A and B) which regulate the expression of exclusive exon regions (solid boxes) 1A and B, respectively, followed a common exons 2&#8211;10 sequence. The dotted diagonal lines indicate the spliced regions from the mature coding transcripts. (<bold>B</bold>) The structure of the SOFA-HDV Rz adopts an off (left panel) and locked configuration secured by the blocker stem in the absence of its specific mRNA target (<italic>Pax</italic>-<italic>5B</italic>). In the presence of the specific substrate (right panel) the SOFA-HDV Rz adopts a catalytically active configuration which is formed through the annealing of the ribozyme's biosensor (BS) and P1 stem (P1) to the target substrate. These structures were previously described in (<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>).</p></caption><graphic xlink:href="gkn432f1"/></fig>
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 725 730 <span type="species:ncbi:9606">human</span>
###xml 755 758 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 770 775 <span type="species:ncbi:9606">human</span>
###xml 1139 1142 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1344 1347 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
At the genetic level, human Pax-5 is mapped to chromosome 9 in region p13 where it is regulated by two distinct promoters regions: first a TATA-containing upstream promoter associated with an exon 1A, and a TATA-less downstream promoter coupled with an exon 1B. Through regulated signaling processes along with the recruitment of specific transcriptional regulators, each promoter induces the transcription of a distinct 5'UTR region and a first exon which then splices to a coding sequence (exons 2-10) common to both transcript isoforms (11,12). These two mRNAs (noted Pax-5A and Pax-5B) are discriminated only by their unique 5'UTR sequence and exon 1 of the coding region (Figure 1A). Figure 1.Schematic structure of the human Pax-5 gene and the SOFA-HDV Rz (A) The human Pax-5 gene located on chromosome 9 includes two alternative promoter regions (empty boxes\promoters A and B) which regulate the expression of exclusive exon regions (solid boxes) 1A and B, respectively, followed a common exons 2-10 sequence. The dotted diagonal lines indicate the spliced regions from the mature coding transcripts. (B) The structure of the SOFA-HDV Rz adopts an off (left panel) and locked configuration secured by the blocker stem in the absence of its specific mRNA target (Pax-5B). In the presence of the specific substrate (right panel) the SOFA-HDV Rz adopts a catalytically active configuration which is formed through the annealing of the ribozyme's biosensor (BS) and P1 stem (P1) to the target substrate. These structures were previously described in (18,19).
###end p 5
###begin p 6
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 37 38 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 65 66 65 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 412 413 412 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 572 575 572 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 576 578 576 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 857 859 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 57 60 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 441 444 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 646 649 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
Schematic structure of the human Pax-5 gene and the SOFA-HDV Rz (A) The human Pax-5 gene located on chromosome 9 includes two alternative promoter regions (empty boxes\promoters A and B) which regulate the expression of exclusive exon regions (solid boxes) 1A and B, respectively, followed a common exons 2-10 sequence. The dotted diagonal lines indicate the spliced regions from the mature coding transcripts. (B) The structure of the SOFA-HDV Rz adopts an off (left panel) and locked configuration secured by the blocker stem in the absence of its specific mRNA target (Pax-5B). In the presence of the specific substrate (right panel) the SOFA-HDV Rz adopts a catalytically active configuration which is formed through the annealing of the ribozyme's biosensor (BS) and P1 stem (P1) to the target substrate. These structures were previously described in (18,19).
###end p 6
###begin p 7
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 191 197 191 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 202 208 202 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 553 559 553 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 596 602 596 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 719 725 719 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 345 350 <span type="species:ncbi:9606">human</span>
###xml 729 734 <span type="species:ncbi:9606">human</span>
Although a great number of studies have contributed to the functional characterization of Pax-5 at the molecular and cellular level, few have discriminated between the physiological roles of Pax-5A and Pax-5B isoforms individually. Given the fact that most Pax-5 bearing cells express both Pax-5 isoforms simultaneously (almost a 1 : 1 ratio in human pre-B cells), the functional study of these alternatively spliced products has proven to be complex and very challenging. As a result, little attention has been paid to the cellular characterization of Pax-5B. Therefore, we set out to develop a Pax-5B gene suppression system using a modified ribozyme (Rz) technology to investigate the specific roles associated with Pax-5B in human B lymphocytes.
###end p 7
###begin p 8
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 967 975 967 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1183 1185 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1424 1432 1424 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1436 1438 1436 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1439 1441 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 488 509 <span type="species:ncbi:12475">hepatitis delta virus</span>
###xml 511 514 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 583 588 <span type="species:ncbi:9606">human</span>
###xml 787 792 <span type="species:ncbi:9606">human</span>
###xml 854 857 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1122 1127 <span type="species:ncbi:9606">human</span>
###xml 1246 1249 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1473 1476 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
The ability of a ribozyme to specifically recognize, and subsequently catalyze the cleavage of an RNA target makes it an attractive molecular tool for the development of gene inactivation systems (13). It provides an interesting alternative to an RNA-interference (RNAi) approach in functional genomics, especially given the recent findings that RNAi specificity is limited and evidence shows that this mechanism can trigger immunological response (14,15). The ribozyme isolated from the hepatitis delta virus (HDV Rz) appears to be the most suited to develop a gene-inactivation in human cells since it has evolved within this particular cell environment (13). In support of this, results have shown this catalytic RNA to be fully active in physiological concentrations of magnesium in human cells (16). However, the target recognition mechanism of the HDV Rz is dependant on the formation of a 7 base pair (bp) between the Rz and the substrate, (namely the P1 stem/Figure 1B). It has been estimated that a minimum sequence of 15 or 16 base pairing nucleotides are required for the targeting of unique RNA species in the human transcriptome, thereby limiting non-specific cleavage (17). In order to fulfill these parameters, a new generation of HDV Rz was engineered which incorporates a Specific On/ofF Adaptor (SOFA) that switches the cleavage activity from off to on solely in the presence of the appropriate substrate (Figure 1B) (18,19). A unique feature of the SOFA-HDV Rz allows it to limit the catalytic activity via a blocking sequence that prevents the folding of the ribozyme into an active conformation. This 'safety lock' function prevents cleavage of a substrate that contains an appropriate P1 stem but lacks a complementary sequence to the SOFA biosensor. This new target-dependent module biosensor bearing Rz significantly reduces non-specific cleavage events.
###end p 8
###begin p 9
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 126 134 126 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 139 146 139 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 203 209 203 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 53 56 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 96 101 <span type="species:ncbi:9606">human</span>
###xml 336 341 <span type="species:ncbi:9606">human</span>
In this study, we developed an isoform-specific SOFA-HDV Rz capable of recognizing and cleaving human Pax-5B transcripts both in vitro and in vivo. Using this gene suppression system, we report that the Pax-5B transcriptional element is associated with changes in target gene activation as well as to the balance of cell fate events in human B lymphocytes.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
Plasmids and ribozyme DNA constructs
###end title 11
###begin p 12
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 273 276 273 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 277 279 277 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 319 322 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 323 325 323 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 367 370 367 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 371 373 371 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 530 533 530 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 536 539 536 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 545 548 545 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
The Pax-5A cDNA was cloned as described previously (20). The Pax-5B transcript was cloned into pBlueScript (SK) (Stratagene, Cedar Creek, Texas) through an RT-PCR amplification on RNA extracts from Ficoll-isolated PBLs (peripheral blood lymphocytes) using specific primers Pax-5B sense 5'-CCGATGGAAATACACTGTAAGC-3' and Pax-5B antisense 5'-CTCCAAGGGTCAGTGACGG-3'. The Pax-5B insert was then subcloned into the pcDNA3.1 expression vector (Invitrogen, Burlington, Ontario, Canada) using a directional cloning technique involving the XhoI, XbaI and NotI restriction sites depending on the insert's original orientation.
###end p 12
###begin p 13
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 4 6 4 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 295 297 295 297 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P1</sub>
###xml 321 325 321 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4-BL</sub>
###xml 453 471 453 471 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TTAATACGACTCACTATA</underline>
###xml 488 493 488 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12-BS</sub>
###xml 496 500 496 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4-BL</sub>
###xml 820 827 820 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 1066 1074 1066 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1248 1256 1248 1256 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1.</label>
###xml 1256 1301 1256 1301 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="14">Nucleotide sequences of Pax-5B target regions</p>
###xml 1256 1301 1256 1301 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="14">Nucleotide sequences of Pax-5B target regions</p></caption>
###xml 1301 1312 1301 1312 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">SOFA-HDV-Rz</th>
###xml 1312 1329 1312 1329 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Targeted sequence</th>
###xml 1301 1329 1301 1329 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">SOFA-HDV-Rz</th><th rowspan="1" colspan="1">Targeted sequence</th></tr>
###xml 1301 1329 1301 1329 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">SOFA-HDV-Rz</th><th rowspan="1" colspan="1">Targeted sequence</th></tr></thead>
###xml 1329 1332 1329 1332 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">B75</td>
###xml 1336 1343 1336 1343 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/ATGGAA</bold>
###xml 1349 1361 1349 1361 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTGTAAGCACGA</underline>
###xml 1332 1364 1332 1364 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CCCG<bold>/ATGGAA</bold> ATACA<underline>CTGTAAGCACGA</underline>CCC</td>
###xml 1329 1364 1329 1364 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">B75</td><td rowspan="1" colspan="1">CCCG<bold>/ATGGAA</bold> ATACA<underline>CTGTAAGCACGA</underline>CCC</td></tr>
###xml 1364 1367 1364 1367 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">B78</td>
###xml 1371 1378 1371 1378 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/GAAATA</bold>
###xml 1383 1395 1383 1395 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAAGCACGACCC</underline>
###xml 1367 1398 1367 1398 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GATG<bold>/GAAATA</bold>CACTG<underline>TAAGCACGACCC</underline>GTT</td>
###xml 1364 1398 1364 1398 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">B78</td><td rowspan="1" colspan="1">GATG<bold>/GAAATA</bold>CACTG<underline>TAAGCACGACCC</underline>GTT</td></tr>
###xml 1398 1401 1398 1401 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">B89</td>
###xml 1405 1412 1405 1412 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/TAAGCA</bold>
###xml 1417 1429 1417 1429 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CGTTTGCATCCA</underline>
###xml 1401 1432 1401 1432 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ACTG<bold>/TAAGCA</bold>CGACC<underline>CGTTTGCATCCA</underline>TGC</td>
###xml 1398 1432 1398 1432 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">B89</td><td rowspan="1" colspan="1">ACTG<bold>/TAAGCA</bold>CGACC<underline>CGTTTGCATCCA</underline>TGC</td></tr>
###xml 1432 1435 1432 1435 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">B93</td>
###xml 1439 1446 1439 1446 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/CACGAC</bold>
###xml 1451 1463 1451 1463 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGCATCCATGCA</underline>
###xml 1435 1466 1435 1466 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TAAG<bold>/CACGAC</bold>CCGTT<underline>TGCATCCATGCA</underline>TAG</td>
###xml 1432 1466 1432 1466 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">B93</td><td rowspan="1" colspan="1">TAAG<bold>/CACGAC</bold>CCGTT<underline>TGCATCCATGCA</underline>TAG</td></tr>
###xml 1466 1469 1466 1469 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">B97</td>
###xml 1473 1480 1473 1480 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/ACCCGT</bold>
###xml 1486 1498 1486 1498 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCCATGCATAGA</underline>
###xml 1469 1501 1469 1501 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CACG<bold>/ACCCGT</bold> TTGCA<underline>TCCATGCATAGA</underline>CAT</td>
###xml 1466 1501 1466 1501 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">B97</td><td rowspan="1" colspan="1">CACG<bold>/ACCCGT</bold> TTGCA<underline>TCCATGCATAGA</underline>CAT</td></tr>
###xml 1329 1501 1329 1501 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">B75</td><td rowspan="1" colspan="1">CCCG<bold>/ATGGAA</bold> ATACA<underline>CTGTAAGCACGA</underline>CCC</td></tr><tr><td rowspan="1" colspan="1">B78</td><td rowspan="1" colspan="1">GATG<bold>/GAAATA</bold>CACTG<underline>TAAGCACGACCC</underline>GTT</td></tr><tr><td rowspan="1" colspan="1">B89</td><td rowspan="1" colspan="1">ACTG<bold>/TAAGCA</bold>CGACC<underline>CGTTTGCATCCA</underline>TGC</td></tr><tr><td rowspan="1" colspan="1">B93</td><td rowspan="1" colspan="1">TAAG<bold>/CACGAC</bold>CCGTT<underline>TGCATCCATGCA</underline>TAG</td></tr><tr><td rowspan="1" colspan="1">B97</td><td rowspan="1" colspan="1">CACG<bold>/ACCCGT</bold> TTGCA<underline>TCCATGCATAGA</underline>CAT</td></tr></tbody>
###xml 1301 1501 1301 1501 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">SOFA-HDV-Rz</th><th rowspan="1" colspan="1">Targeted sequence</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">B75</td><td rowspan="1" colspan="1">CCCG<bold>/ATGGAA</bold> ATACA<underline>CTGTAAGCACGA</underline>CCC</td></tr><tr><td rowspan="1" colspan="1">B78</td><td rowspan="1" colspan="1">GATG<bold>/GAAATA</bold>CACTG<underline>TAAGCACGACCC</underline>GTT</td></tr><tr><td rowspan="1" colspan="1">B89</td><td rowspan="1" colspan="1">ACTG<bold>/TAAGCA</bold>CGACC<underline>CGTTTGCATCCA</underline>TGC</td></tr><tr><td rowspan="1" colspan="1">B93</td><td rowspan="1" colspan="1">TAAG<bold>/CACGAC</bold>CCGTT<underline>TGCATCCATGCA</underline>TAG</td></tr><tr><td rowspan="1" colspan="1">B97</td><td rowspan="1" colspan="1">CACG<bold>/ACCCGT</bold> TTGCA<underline>TCCATGCATAGA</underline>CAT</td></tr></tbody></table>
###xml 1501 1545 1501 1545 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="15">(/) indicates the cleavage site of ribozyme.</p>
###xml 1545 1635 1545 1635 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="16">The complementary sequence to the P1 binding site of the SOFA-HDV-Rz is indicated in bold.</p>
###xml 1635 1711 1635 1711 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="17">The complementary sequence to the biosensor of the SOFA-HDV-Rz is underlined</p>
###xml 1501 1711 1501 1711 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="15">(/) indicates the cleavage site of ribozyme.</p><p textid="16">The complementary sequence to the P1 binding site of the SOFA-HDV-Rz is indicated in bold.</p><p textid="17">The complementary sequence to the biosensor of the SOFA-HDV-Rz is underlined</p></fn>
###xml 1501 1711 1501 1711 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn><p textid="15">(/) indicates the cleavage site of ribozyme.</p><p textid="16">The complementary sequence to the P1 binding site of the SOFA-HDV-Rz is indicated in bold.</p><p textid="17">The complementary sequence to the biosensor of the SOFA-HDV-Rz is underlined</p></fn></table-wrap-foot>
###xml 1248 1711 1248 1711 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1.</label><caption><p textid="14">Nucleotide sequences of Pax-5B target regions</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">SOFA-HDV-Rz</th><th rowspan="1" colspan="1">Targeted sequence</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">B75</td><td rowspan="1" colspan="1">CCCG<bold>/ATGGAA</bold> ATACA<underline>CTGTAAGCACGA</underline>CCC</td></tr><tr><td rowspan="1" colspan="1">B78</td><td rowspan="1" colspan="1">GATG<bold>/GAAATA</bold>CACTG<underline>TAAGCACGACCC</underline>GTT</td></tr><tr><td rowspan="1" colspan="1">B89</td><td rowspan="1" colspan="1">ACTG<bold>/TAAGCA</bold>CGACC<underline>CGTTTGCATCCA</underline>TGC</td></tr><tr><td rowspan="1" colspan="1">B93</td><td rowspan="1" colspan="1">TAAG<bold>/CACGAC</bold>CCGTT<underline>TGCATCCATGCA</underline>TAG</td></tr><tr><td rowspan="1" colspan="1">B97</td><td rowspan="1" colspan="1">CACG<bold>/ACCCGT</bold> TTGCA<underline>TCCATGCATAGA</underline>CAT</td></tr></tbody></table><table-wrap-foot><fn><p textid="15">(/) indicates the cleavage site of ribozyme.</p><p textid="16">The complementary sequence to the P1 binding site of the SOFA-HDV-Rz is indicated in bold.</p><p textid="17">The complementary sequence to the biosensor of the SOFA-HDV-Rz is underlined</p></fn></table-wrap-foot></table-wrap>
###xml 21 24 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 89 92 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 850 853 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1306 1309 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1607 1610 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1691 1694 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
Pax-5B specific SOFA-HDV Rz were constructed as described previously (18). Briefly, SOFA-HDV Rz were constructed using a PCR-based strategy that included two complementary and overlapping oligodeoxynucleotides: the antisense oligonucleotide 5'-CCAGCTAGAAAGGGTCCCTTAGCCATCCGCGAACGGATGCCC(ANNNNNN)P1ACCGCGAGGAGGTGGACCCTG(N)4-BL-3' (where N is A, C, G or T, P1 and BL indicate the P1 strand region and the blocker sequence, respectively) and, the sense 5'-TTAATACGACTCACTATAGGGCCAGCTAGTTT(N)12-BS(N)4-BLCAGGGTCCACC-3' (where N is A, C, G or T, BS indicates biosensor sequence and BL the blocker sequence, respectively) that permitted the incorporation of the T7 RNA promoter (underlined). It is important to note that the (N) segments vary in sequence depending on the targeted site accessible on the target RNA substrate (Table 1). The DNA coding SOFA-HDV Rz were rendered double stranded by PCR which were later purified by phenol:chloroform extraction, precipitated with ethanol and dissolved in water. The double-stranded DNA (dsDNA) fragments were either used for in vitro transcriptions (described below), or cloned without the T7 promoter region into a polymerase III-based expression vector psiRNA-hH1-GFP/Zeo (Invivogen, San Diego, CA, USA). Table 1.Nucleotide sequences of Pax-5B target regionsSOFA-HDV-RzTargeted sequenceB75CCCG/ATGGAA ATACACTGTAAGCACGACCCB78GATG/GAAATACACTGTAAGCACGACCCGTTB89ACTG/TAAGCACGACCCGTTTGCATCCATGCB93TAAG/CACGACCCGTTTGCATCCATGCATAGB97CACG/ACCCGT TTGCATCCATGCATAGACAT(/) indicates the cleavage site of ribozyme.The complementary sequence to the P1 binding site of the SOFA-HDV-Rz is indicated in bold.The complementary sequence to the biosensor of the SOFA-HDV-Rz is underlined
###end p 13
###begin p 14
Nucleotide sequences of Pax-5B target regions
###end p 14
###begin p 15
(/) indicates the cleavage site of ribozyme.
###end p 15
###begin p 16
###xml 62 65 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
The complementary sequence to the P1 binding site of the SOFA-HDV-Rz is indicated in bold.
###end p 16
###begin p 17
###xml 56 59 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
The complementary sequence to the biosensor of the SOFA-HDV-Rz is underlined
###end p 17
###begin title 18
RNA synthesis
###end title 18
###begin p 19
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HindIII</italic>
###xml 124 127 124 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 128 130 128 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 517 518 505 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 10 13 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1201 1204 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
Both SOFA-HDV Rz and substrates were synthesized by run-off transcription from PCR products and HindIII linearized pcDNA3.1-Pax-5B templates, respectively, as described previously (18). Briefly, transcriptions were performed in the presence of purified T7 RNA polymerase (10 microg), RNA Guard (24 U, Amersham Biosciences), pyrophosphatase (0.01 U, Roche Diagnostics, Laval, QC, Canada) and either linearized plasmid DNA (5 microg) or PCR product (2-5 microM) in a buffer containing 80 mM HEPES-KOH pH 7.5, 24 mM MgCl2, 2 mM spermidine, 40 mM DTT, 5 mM of each NTP in a final volume of 100 microl at 37degreesC for 2-4 h. Upon completion, the reaction mixtures were treated with DNase RQ1 (Amersham Biosciences, Piscataway, NJ) at 37degreesC for 20 min, the RNA purified by phenol:chloroform extraction and then precipitated with ethanol. The RNA products were fractionated by denaturing (6 or 10%) polyacrylamide gel electrophoresis (PAGE; 19 : 1 ratio of acrylamide to bisacrylamide) in buffer containing 45 mM Tris-borate pH 7.5, 7 M urea and 1 mM EDTA. The reaction products were visualized either by UV shadowing or autoradiography. The bands corresponding to the correct sizes for both the SOFA-HDV Rz and substrate RNA molecules were cut out and the transcripts eluted overnight at room temperature. The transcripts were desalted on Sephadex G-25 (Amersham Biosciences) spun-columns, and were then ethanol precipitated and quantified by absorbance at 260 nm.
###end p 19
###begin title 20
Ribozyme cleavage assays
###end title 20
###begin p 21
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 348 350 338 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 459 460 442 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 28 31 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 307 310 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
The conditions for the SOFA-HDV Rz cleavage assays have been described previously (18). Briefly, in all reactions the ribozymes and substrate were preincubated together at 37degreesC for 2-5 min; thereafter, the magnesium was added to initiate the cleavage reaction. Reactions were performed using 1 microM HDV Rz and trace amounts of 5'-terminal [32P]-labeled substrate at 37degreesC in a final volume of 10 mul containing 50 mM Tris-HCl pH 7.5 and 5 mM MgCl2. Experiments were incubated at 37degreesC for 2.5 h, stopped by the addition of ice-cold formamide dye buffer (5 microl of 97% formamide, 10 mM EDTA pH 8.0, 0.025% xylene cyanol and 0.025% bromophenol blue), electrophoresed on an 8% PAGE gel and exposed onto a PhosphorImager screen (Molecular Dynamics, Sunnyvale, CA, USA).
###end p 21
###begin title 22
Cells lines and transfections
###end title 22
###begin p 23
###xml 343 346 343 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 347 349 347 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 606 607 606 607 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
###xml 548 554 <span type="species:ncbi:9913">bovine</span>
HEK293 and 293T cells (human embryonic kidney) were obtained from the American Type Culture Collection (Rockville, MD, USA) and the REH (acute lymphocytic leukemia cells) cell line was kindly provided by Dr Edward A. Clark, University of Washington Medical Center, Seattle. We also made of HEK293 stably transfected with the full length human Pax-5B coding region, the HEK 293-B2 cell line, which was created in our laboratory. Cell lines were maintained in complete culture medium made of DMEM (HEK) or RPMI-1640 (REH) supplemented with 10% fetal bovine serum (FBS; Hyclone Laboratories, Logan, UT, USA), l-glutamine (2 mM), penicillin G (100 U/ml), and streptomycin (100 microg/ml) (Invitrogen). Cells were either left untreated or treated (as described in figure legends) with 2 microM of Actimomycin D (Sigma, St Louis, Missouri).
###end p 23
###begin p 24
###xml 235 236 235 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Transient transfections of the HEK cell lines and stably transfected REH cells were conducted using the Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Briefly, cells were seeded into 6-well plates (2 x 105/well) where they received a total of 2 mug (or indicated otherwise) of plasmid DNA that was complexed with the provided transfection reagent.
###end p 24
###begin title 25
Northern Blot hybridizations
###end title 25
###begin p 26
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 108 110 104 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 129 132 125 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 133 135 129 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 224 226 216 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 249 252 241 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 253 255 245 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 271 275 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 328 330 317 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
Northern blot analyses were performed as described previously (18) using 10 microg of RNA isolated by TrizolTM (Invitrogen). The Pax-5B probe was obtained by a T3 RNA polymerase-based transcription in the presence of [alpha-32P]UTP on a pBlueScript Pax-5B construct. The beta-actin RNA probe used was prepared using the Strip-EZTM RNA T7/T3 kit (Ambion, Austin, TX, USA). All hybridizations were carried out for 16-18 h at 65degreesC. The membranes were then exposed to PhosphorImager screens for 2-24 h and thereafter analyzed on a radioanalytic scanner (Storm, Amersham Biosciences).
###end p 26
###begin title 27
Preparation of nuclear extracts and electrophoretic mobility shift assays (EMSA)
###end title 27
###begin p 28
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 183 184 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 643 644 641 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 946 947 937 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1523 1525 1499 1501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1636 1638 1608 1610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1471 1477 <span type="species:ncbi:9913">bovine</span>
Nuclear extracts were prepared according to the previously described microscale preparation protocol and analyzed by gel shift assays previously described (20). Briefly, cells (5 x 106) were washed with ice-cold PBS and resuspended in 400 mul of cold buffer A [10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; pH 7.9), 10 mM KCl, 0.1 mM EGTA, 0.1 mM EDTA, 1 mM DTT, and 0.5 mM phenylmethylsulfonyl fluoride (PMSF)]. The cells were allowed to swell on ice for 15 min, after which 25 mul of a 10% solution of Nonidet P-40 was added and the tube was vigorously vortexed for 30 s. The homogenate was centrifuged for 10 s at 12 000g. The supernatant fraction was discarded and the pellet was resuspended in 50 mul of cold buffer C [20 mM HEPES-KOH (pH 7.9), 0.4 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT and 1 mM PMSF] and incubated at 4degreesC for 15 min on a shaking platform. Cellular debris were removed by centrifugation at 12 000g for 20 min at 4degreesC and the supernatant fractions were stored at -270degreesC until used. Ten micrograms of nuclear extracts were used to perform EMSA as determined by the bicinchoninic acid assay (BCA) with a commercial protein assay reagent (Pierce, Rockford, IL, USA). Nuclear extracts were incubated for 20 min at room temperature in 20 mul of the binding buffer (100 mM HEPES (pH 7.9), 40% glycerol, 10% Ficoll, 250 mM KCl, 10 mM dithiothreitol, 5 mM EDTA, 250 mM NaCl, 2 mug poly (dI-dC) and 10 mug nuclease-free bovine serum albumin fraction V) containing 1 ng of 32P-5'-end-labeled double-stranded (dsDNA) oligonucleotide. Double-stranded DNA (100 ng) was labeled with [gamma-32P]ATP and T4 polynucleotide kinase in a kinase buffer (New England Biolabs, Beverly, MA, USA). This mixture was incubated for 30 min at 37degreesC and the reactions were stopped with 5 mul of 0.2 M EDTA. The labeled oligonucleotides were extracted with phenol/chloroform and passed through a G-50 spin column. The dsDNA oligonucleotides, which were used as probes, contained the consensus NF-kappaB and the BSAP sites corresponding to the sequences 5'-ATGTGAGGGGACTTTCCCAGGC-3' and 5'-GAATGGGGCACTGAGGCGTG-3', respectively. The DNA-protein complexes were migrated on a 4% (w/v) polyacrylamide gel containing Tris-Borate-EDTA. The gels were then subsequently dried and autoradiographed. Cold-competition assays were carried out by adding a 100-fold molar excess of unlabeled dsDNA oligonucleotide simultaneously with the labeled probe.
###end p 28
###begin title 29
Quantitative RT-PCR and mRNA half-life analysis
###end title 29
###begin p 30
###xml 661 664 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 665 667 623 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 857 861 815 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1010 1012 948 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct</italic>
###xml 1045 1047 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1087 1118 1025 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hypoxanthine ribosyltransferase</italic>
###xml 1120 1124 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 1549 1551 1486 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 152 157 <span type="species:ncbi:9606">human</span>
###xml 744 747 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
Levels of gene expression were verified by quantiative PCR. Reaction mixtures were composed of 20 nM each sense and antisense primers and 0.1 microg of human total cDNA, diluted in water to a total of 12.5 microl and mixed with 12.5 microl of 2X iQ SYBR Green Supermix (BioRad, Mississauga, Ontario, Canada) where they were run in a Smart Cycler II real-time PCR apparatus (Cepheid, Sunnyvale, CA, USA) with the following parameters: 2 min initial denaturation, 35 cycles of 1 min at 94degreesC, 1 min at 55degreesC (optics on), 1 min at 72degreesC, followed by melt curve analysis from 65degreesC to 95degreesC. Quantitative PCR applications were conducted on Pax-5B sense 5'-TTGGCACGAGGTAGACAC-3' and antisense 5'-AGCCCTCCAACACTGAGA-3'; SOFA-HDV Rz sense 5'-ATCCATCGGGTACCGGGCCAGCTAGTTT-3' and antisense 5'-CCAGCTAGAAAGGGTCCCTTAGCCATCCGCG-3'; and finally CD19 sense 5'-CCACCTGGAGATCACTG-3' and antisense 5'-ATAAGCCAAAGTCACAGC-3'. Comparative expression levels were calculated using the triangle uptriangle upCt method of Livak and Schmittgen (21), with the endogenously expressed gene hypoxanthine ribosyltransferase (HPRT) using sense 5'-TGACACTGGCAAAACAATGCA-3' and antisense 5'-GGTCCTTTTCACCAGCAAGCT-3' primers as the internal control. Amplification efficiencies were also considered and calculated for all real-time amplification products (data not shown). Where applicable, transcript decay rates were performed through the use of quantitative RT-PCR on RNA extracts from REH cells treated with actimomycin-D (2 muM) as previously described (22).
###end p 30
###begin title 31
Flow cytometry analysis
###end title 31
###begin p 32
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 85 86 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 150 154 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 429 435 <span type="species:ncbi:10090">murine</span>
Cells (106) were incubated for 30 min on ice with saturating concentrations (1 mug/106 cells) of PE-conjugated monoclonal antibodies directed against CD19 or HLA-DR (BD Bioscience, Mississauga, Ontario, Canada). Finally, cells were resuspended in 500 mul of phosphate-buffered saline (PBS) before flow cytometry analysis (FACS Calibur, BD Biosciences, Miami, FL, USA). Controls consisted of commercial isotype-matched irrelevant murine monoclonal antibodies (Sigma, Oakville, Ontario, Canada) (10 000 events/sample).
###end p 32
###begin title 33
Cell proliferation and apoptosis assays
###end title 33
###begin p 34
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 534 536 532 534 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ex</sub>
###xml 540 542 538 540 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Em</sub>
###xml 706 708 700 702 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ex</sub>
###xml 712 714 706 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Em</sub>
Cells (107) were seeded in 96 well plates and analyzed in time for cellular viability and apoptotic events using a multiplexed assay of CellTiter Blue (Promega, Madison, WI, USA) and Apo-One (Promega) assay kits, respectively, according to the manufacturer's instructions. Briefly, 20 mul of the CellTiter Blue substrate was added to 100 mul of cell suspension and incubated for 1 h at room temperature on a plate shaker. Thereafter, the plate was subjected to a colorimetric analysis and read on a fluorescence microplate reader (560Ex/590Em). Apoptotic events were then measured on the same microplate by the addition of 120 microl of Apo-ONE, incubated for another hour and analyzed by fluorescence (485Ex/527Em).
###end p 34
###begin title 35
RESULTS
###end title 35
###begin p 36
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 393 396 393 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 397 398 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 405 413 405 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1165 1168 1165 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1169 1171 1169 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1225 1234 1225 1234 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 1251 1259 1251 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1355 1358 1355 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1359 1361 1359 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1418 1421 1418 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1422 1424 1422 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1537 1545 1537 1545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1596 1598 1596 1598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1634 1637 1634 1637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1638 1640 1638 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5A</italic>
###xml 1645 1648 1645 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1649 1651 1649 1651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1678 1681 1678 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1682 1684 1682 1684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1234 2002 1234 1978 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="37">Autoradiogram of <italic>in vitro</italic> cleavage assays showing the cleavage specificity of the SOFA-HDV Rz directed against the human <italic>Pax</italic>-<italic>5B</italic> transcript. SOFA-HDV Rz were tailored against the human <italic>Pax</italic>-<italic>5B</italic> mRNA (above sequence) to target nucleotide positions 75, 78, 89, 93 and 97 of the exon 1 region (black arrows). <italic>In vitro</italic> cleavage assays were performed using 5&#8242; terminal [<sup>32</sup>P]-labeled RNA regions of the human <italic>Pax</italic>-<italic>5A</italic> and <italic>Pax</italic>-<italic>5B</italic> transcript incubated with <italic>Pax</italic>-<italic>5B</italic>-specific SOFA-HDV Rz-B75, -B78, -B89, -B93 and -B97 and then migrated on to a 5% polyacrylamide gel and autoradiographed. On the right of the panel, &#8216;S&#8217; indicates the substrates (&#8764;600 bases), &#8216;Rz&#8217; indicates the SOFA-HDV Rz and &#8216;P&#8217; indicates the 5&#8242; terminal cleaved products (&#8764;75 and 78 bases).</p>
###xml 1234 2002 1234 1978 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="37">Autoradiogram of <italic>in vitro</italic> cleavage assays showing the cleavage specificity of the SOFA-HDV Rz directed against the human <italic>Pax</italic>-<italic>5B</italic> transcript. SOFA-HDV Rz were tailored against the human <italic>Pax</italic>-<italic>5B</italic> mRNA (above sequence) to target nucleotide positions 75, 78, 89, 93 and 97 of the exon 1 region (black arrows). <italic>In vitro</italic> cleavage assays were performed using 5&#8242; terminal [<sup>32</sup>P]-labeled RNA regions of the human <italic>Pax</italic>-<italic>5A</italic> and <italic>Pax</italic>-<italic>5B</italic> transcript incubated with <italic>Pax</italic>-<italic>5B</italic>-specific SOFA-HDV Rz-B75, -B78, -B89, -B93 and -B97 and then migrated on to a 5% polyacrylamide gel and autoradiographed. On the right of the panel, &#8216;S&#8217; indicates the substrates (&#8764;600 bases), &#8216;Rz&#8217; indicates the SOFA-HDV Rz and &#8216;P&#8217; indicates the 5&#8242; terminal cleaved products (&#8764;75 and 78 bases).</p></caption>
###xml 2002 2002 1978 1978 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn432f2"/>
###xml 1225 2002 1225 1978 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="37">Autoradiogram of <italic>in vitro</italic> cleavage assays showing the cleavage specificity of the SOFA-HDV Rz directed against the human <italic>Pax</italic>-<italic>5B</italic> transcript. SOFA-HDV Rz were tailored against the human <italic>Pax</italic>-<italic>5B</italic> mRNA (above sequence) to target nucleotide positions 75, 78, 89, 93 and 97 of the exon 1 region (black arrows). <italic>In vitro</italic> cleavage assays were performed using 5&#8242; terminal [<sup>32</sup>P]-labeled RNA regions of the human <italic>Pax</italic>-<italic>5A</italic> and <italic>Pax</italic>-<italic>5B</italic> transcript incubated with <italic>Pax</italic>-<italic>5B</italic>-specific SOFA-HDV Rz-B75, -B78, -B89, -B93 and -B97 and then migrated on to a 5% polyacrylamide gel and autoradiographed. On the right of the panel, &#8216;S&#8217; indicates the substrates (&#8764;600 bases), &#8216;Rz&#8217; indicates the SOFA-HDV Rz and &#8216;P&#8217; indicates the 5&#8242; terminal cleaved products (&#8764;75 and 78 bases).</p></caption><graphic xlink:href="gkn432f2"/></fig>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 271 274 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 387 392 <span type="species:ncbi:9606">human</span>
###xml 498 501 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 728 731 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1017 1020 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1133 1136 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1187 1192 <span type="species:ncbi:9606">human</span>
###xml 1321 1324 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1349 1354 <span type="species:ncbi:9606">human</span>
###xml 1379 1382 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1412 1417 <span type="species:ncbi:9606">human</span>
###xml 1628 1633 <span type="species:ncbi:9606">human</span>
###xml 1699 1702 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1913 1916 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
In order to investigate the functional role of the human Pax-5B transcription factor, we have developed a RNA-based gene suppression system which has the ability to specifically recognize, bind and cleave an RNA substrate in a sequence-specific manner. The specific SOFA-HDV Rz were designed to target sequences within the exon 1B that includes non-translated and coding sequence of the human Pax-5 gene (Figure 2). Target sequences were identified considering the substrate preference of the SOFA-HDV Rz (i.e. a guanosine residue in position +1 of the cleavage site, no guanosine in position -1, and no two consecutive pyrimidines in positions -1 and -2 (23). Moreover, in order to ensure the substrate specificity of the SOFA-HDV Rz, the sequences targeted were analyzed using RiboSubstrates, an integrated bioinformatics software that enables a search of a cDNA database for all potential substrates for a given ribozyme (24). This includes the mRNAs that perfectly match the specific requirements of a given SOFA-HDV Rz, as well those including wobble and mismatches base pairings. These analyses revealed that the designed SOFA-HDV Rz should solely cleave the Pax-5B mRNAs from the human transcriptome (data not shown). Figure 2.Autoradiogram of in vitro cleavage assays showing the cleavage specificity of the SOFA-HDV Rz directed against the human Pax-5B transcript. SOFA-HDV Rz were tailored against the human Pax-5B mRNA (above sequence) to target nucleotide positions 75, 78, 89, 93 and 97 of the exon 1 region (black arrows). In vitro cleavage assays were performed using 5' terminal [32P]-labeled RNA regions of the human Pax-5A and Pax-5B transcript incubated with Pax-5B-specific SOFA-HDV Rz-B75, -B78, -B89, -B93 and -B97 and then migrated on to a 5% polyacrylamide gel and autoradiographed. On the right of the panel, 'S' indicates the substrates (approximately600 bases), 'Rz' indicates the SOFA-HDV Rz and 'P' indicates the 5' terminal cleaved products (approximately75 and 78 bases).
###end p 36
###begin p 37
###xml 17 25 17 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 125 127 125 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 188 190 188 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 303 311 303 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 362 364 362 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 400 403 400 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 404 406 404 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5A</italic>
###xml 411 414 411 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 415 417 415 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 444 447 444 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 448 450 448 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 87 90 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 115 120 <span type="species:ncbi:9606">human</span>
###xml 145 148 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 178 183 <span type="species:ncbi:9606">human</span>
###xml 394 399 <span type="species:ncbi:9606">human</span>
###xml 465 468 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 679 682 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
Autoradiogram of in vitro cleavage assays showing the cleavage specificity of the SOFA-HDV Rz directed against the human Pax-5B transcript. SOFA-HDV Rz were tailored against the human Pax-5B mRNA (above sequence) to target nucleotide positions 75, 78, 89, 93 and 97 of the exon 1 region (black arrows). In vitro cleavage assays were performed using 5' terminal [32P]-labeled RNA regions of the human Pax-5A and Pax-5B transcript incubated with Pax-5B-specific SOFA-HDV Rz-B75, -B78, -B89, -B93 and -B97 and then migrated on to a 5% polyacrylamide gel and autoradiographed. On the right of the panel, 'S' indicates the substrates (approximately600 bases), 'Rz' indicates the SOFA-HDV Rz and 'P' indicates the 5' terminal cleaved products (approximately75 and 78 bases).
###end p 37
###begin title 38
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 5 8 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 50 55 <span type="species:ncbi:9606">human</span>
SOFA-HDV Rz specifically cleave their appropriate human Pax-5 RNA substrate in vitro
###end title 38
###begin p 39
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 149 155 149 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 168 176 168 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 265 271 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 385 391 385 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 425 431 425 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 558 561 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 562 564 562 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 703 709 703 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 860 866 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 890 896 878 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 957 963 945 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 1131 1139 1119 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 95 98 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
###xml 184 187 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 259 264 <span type="species:ncbi:9606">human</span>
###xml 300 303 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 485 488 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 756 759 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1017 1020 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1244 1247 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1259 1262 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
In vitro cleavage assays were first conducted to evaluate the catalytic potential of each SOFA-HDV Rz directed against a partial region of the human Pax-5B transcript (Figure 2). SOFA-HDV Rz directed against the sequence position 75, 78, 89, 93 and 97 of the human Pax-5B mRNA sequence (labeled SOFA-HDV Rz-B75, -B78, -B89, -B93 and -B97, respectively) were incubated with a specific (Pax-5B) as well as with a non-specific (Pax-5A) RNA substrate. Following an incubation period, SOFA-HDV Rz-B75 and B78, efficiently recognized and cleaved their appropriate Pax-5B substrate (i.e. with 25.1 and 25.4% cleavage, respectively) while no observable cleaved products appeared in the reactions containing the Pax-5A RNA fragments. In the three other tests, SOFA-HDV Rz exhibited only minimal cleavage activity (approximately1-2%) while no detectable cleavage of the Pax-5A mRNA was observed with Pax-5B specific ribozymes. The absence of cleavage activity of the Pax-5A-derived transcripts is an illustration that the SOFA-HDV Rz do not elaborate off-target cleavage activity in the presence of non-specific substrates. Importantly, the in vitro experiments led to the identification of two ribozymes possessing the greatest catalytic activity (SOFA-HDV Rz-B75 and HDV Rz-B78).
###end p 39
###begin title 40
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 27 29 27 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 5 8 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
SOFA-HDV Rz suppressed Pax-5B intracellular levels in a dose-dependent manner
###end title 40
###begin p 41
###xml 117 120 117 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 121 123 121 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 216 219 216 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 220 222 220 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 313 321 313 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 473 476 473 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 477 479 477 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 587 595 587 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 672 678 672 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 699 707 699 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 800 803 800 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 804 806 804 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 897 905 897 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 991 999 991 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1069 1072 1069 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1073 1075 1073 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1468 1474 1468 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 1551 1557 1551 1557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1692 1701 1692 1701 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 1701 1708 1701 1708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 1805 1811 1805 1811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1828 1829 1828 1829 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1927 1930 1927 1930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1931 1933 1931 1933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 2137 2140 2136 2139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 2141 2143 2140 2142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 2196 2199 2195 2198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 2200 2202 2199 2201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 2261 2264 2260 2263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 2265 2267 2264 2266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 2419 2422 2418 2421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 2423 2425 2422 2424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 2489 2492 2488 2491 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 2531 2537 2530 2536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 2799 2800 2798 2799 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2918 2921 2917 2920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 2922 2924 2921 2923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 2991 2996 2990 2995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 3103 3105 3094 3096 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 3360 3365 3351 3356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 3549 3552 3536 3539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 3553 3555 3540 3542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 3593 3596 3580 3583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 3597 3599 3584 3586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 3630 3636 3617 3623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1701 3699 1701 3686 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="42"><italic>In vivo</italic> evaluation of genetically engineered SOFA-HDV Rz to suppress the expression levels of the human <italic>Pax-5B</italic> gene products. (<bold>A</bold>) Northern analysis were conducted on RNA extracts from 293T cells transiently cotransfected with <italic>Pax</italic>-<italic>5B</italic> (500 ng); increasing amounts of SOFA-HDV Rz (1, 100 and 1000 ng) and finally filler DNA to totalize 1.5 &#956;g. Individual controls are indicated as the untransfected cells (293T); cells cotransfected with <italic>Pax</italic>-<italic>5B</italic> along with the SOFA-HDV Rz empty vector (identified <italic>Pax</italic>-<italic>5B</italic>); and cells cotransfected with SOFA-HDV Rz along with the <italic>Pax</italic>-<italic>5B</italic> empty vector (identified Rz). Radiolabeled RNA probes were then hybridized onto the membrane to reveal transcript expression levels from intracellular <italic>Pax</italic>-<italic>5B</italic> (top panel) and actin (bottom panel) as an internal reference. <bold>(B)</bold> The radioactivity from the hybridized <italic>Pax-5B</italic> probes was then calculated and normalized on actin transcripts densities using a radioanalytic scanner and plotted with error bars in relation to expression ratios (in black). SOFA-HDV Rz RNA levels are also plotted accordingly (right of the panel, in white). (<bold>C</bold>) Electrophorectic Mobility Shift Assays (EMSA) were conducted on nuclear extracts from 293T cells cotransfected with <italic>Pax</italic>-<italic>5B</italic> and SOFA-HDV Rz. Nuclear extracts were incubated with either with <italic>Pax-5</italic> (top panel) or NF-&#954;B-specific (bottom panel) dsDNA oligonucleotides labeled at the 5&#8242; end with [&#947;-<sup>32</sup>P]. DNA&#8211;protein complexes were resolved and analyzed on a 4% polyacrylamide gel. Specific (S) and non-specific (NS) cold competition (Comp) assays were carried out by adding a 100-fold molar excess of unlabeled dsDNA oligonucleotides corresponding to the <italic>Pax-5</italic> or the NF-&#954;B consensus-binding motif. Control lanes were loaded with free probe (Probe) and extracts from untouched 293T cells (293T). Other controls include transfections of the <italic>Pax</italic>-<italic>5B</italic> empty vector (identified pcDNA), the <italic>Pax</italic>-<italic>5B</italic> expression vector (identified <italic>Pax-5B</italic>) and finally the SOFA-HDV Rz empty vector (identified psiRNA).</p>
###xml 1701 3699 1701 3686 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="42"><italic>In vivo</italic> evaluation of genetically engineered SOFA-HDV Rz to suppress the expression levels of the human <italic>Pax-5B</italic> gene products. (<bold>A</bold>) Northern analysis were conducted on RNA extracts from 293T cells transiently cotransfected with <italic>Pax</italic>-<italic>5B</italic> (500 ng); increasing amounts of SOFA-HDV Rz (1, 100 and 1000 ng) and finally filler DNA to totalize 1.5 &#956;g. Individual controls are indicated as the untransfected cells (293T); cells cotransfected with <italic>Pax</italic>-<italic>5B</italic> along with the SOFA-HDV Rz empty vector (identified <italic>Pax</italic>-<italic>5B</italic>); and cells cotransfected with SOFA-HDV Rz along with the <italic>Pax</italic>-<italic>5B</italic> empty vector (identified Rz). Radiolabeled RNA probes were then hybridized onto the membrane to reveal transcript expression levels from intracellular <italic>Pax</italic>-<italic>5B</italic> (top panel) and actin (bottom panel) as an internal reference. <bold>(B)</bold> The radioactivity from the hybridized <italic>Pax-5B</italic> probes was then calculated and normalized on actin transcripts densities using a radioanalytic scanner and plotted with error bars in relation to expression ratios (in black). SOFA-HDV Rz RNA levels are also plotted accordingly (right of the panel, in white). (<bold>C</bold>) Electrophorectic Mobility Shift Assays (EMSA) were conducted on nuclear extracts from 293T cells cotransfected with <italic>Pax</italic>-<italic>5B</italic> and SOFA-HDV Rz. Nuclear extracts were incubated with either with <italic>Pax-5</italic> (top panel) or NF-&#954;B-specific (bottom panel) dsDNA oligonucleotides labeled at the 5&#8242; end with [&#947;-<sup>32</sup>P]. DNA&#8211;protein complexes were resolved and analyzed on a 4% polyacrylamide gel. Specific (S) and non-specific (NS) cold competition (Comp) assays were carried out by adding a 100-fold molar excess of unlabeled dsDNA oligonucleotides corresponding to the <italic>Pax-5</italic> or the NF-&#954;B consensus-binding motif. Control lanes were loaded with free probe (Probe) and extracts from untouched 293T cells (293T). Other controls include transfections of the <italic>Pax</italic>-<italic>5B</italic> empty vector (identified pcDNA), the <italic>Pax</italic>-<italic>5B</italic> expression vector (identified <italic>Pax-5B</italic>) and finally the SOFA-HDV Rz empty vector (identified psiRNA).</p></caption>
###xml 3699 3699 3686 3686 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn432f3"/>
###xml 1692 3699 1692 3686 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="42"><italic>In vivo</italic> evaluation of genetically engineered SOFA-HDV Rz to suppress the expression levels of the human <italic>Pax-5B</italic> gene products. (<bold>A</bold>) Northern analysis were conducted on RNA extracts from 293T cells transiently cotransfected with <italic>Pax</italic>-<italic>5B</italic> (500 ng); increasing amounts of SOFA-HDV Rz (1, 100 and 1000 ng) and finally filler DNA to totalize 1.5 &#956;g. Individual controls are indicated as the untransfected cells (293T); cells cotransfected with <italic>Pax</italic>-<italic>5B</italic> along with the SOFA-HDV Rz empty vector (identified <italic>Pax</italic>-<italic>5B</italic>); and cells cotransfected with SOFA-HDV Rz along with the <italic>Pax</italic>-<italic>5B</italic> empty vector (identified Rz). Radiolabeled RNA probes were then hybridized onto the membrane to reveal transcript expression levels from intracellular <italic>Pax</italic>-<italic>5B</italic> (top panel) and actin (bottom panel) as an internal reference. <bold>(B)</bold> The radioactivity from the hybridized <italic>Pax-5B</italic> probes was then calculated and normalized on actin transcripts densities using a radioanalytic scanner and plotted with error bars in relation to expression ratios (in black). SOFA-HDV Rz RNA levels are also plotted accordingly (right of the panel, in white). (<bold>C</bold>) Electrophorectic Mobility Shift Assays (EMSA) were conducted on nuclear extracts from 293T cells cotransfected with <italic>Pax</italic>-<italic>5B</italic> and SOFA-HDV Rz. Nuclear extracts were incubated with either with <italic>Pax-5</italic> (top panel) or NF-&#954;B-specific (bottom panel) dsDNA oligonucleotides labeled at the 5&#8242; end with [&#947;-<sup>32</sup>P]. DNA&#8211;protein complexes were resolved and analyzed on a 4% polyacrylamide gel. Specific (S) and non-specific (NS) cold competition (Comp) assays were carried out by adding a 100-fold molar excess of unlabeled dsDNA oligonucleotides corresponding to the <italic>Pax-5</italic> or the NF-&#954;B consensus-binding motif. Control lanes were loaded with free probe (Probe) and extracts from untouched 293T cells (293T). Other controls include transfections of the <italic>Pax</italic>-<italic>5B</italic> empty vector (identified pcDNA), the <italic>Pax</italic>-<italic>5B</italic> expression vector (identified <italic>Pax-5B</italic>) and finally the SOFA-HDV Rz empty vector (identified psiRNA).</p></caption><graphic xlink:href="gkn432f3"/></fig>
###xml 100 103 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 264 267 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 467 472 <span type="species:ncbi:9606">human</span>
###xml 639 642 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 816 819 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 972 977 <span type="species:ncbi:9606">human</span>
###xml 1246 1249 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1650 1653 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1751 1754 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1799 1804 <span type="species:ncbi:9606">human</span>
###xml 1971 1974 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 2164 2167 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 2239 2242 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 2719 2722 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 2934 2937 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 3659 3662 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
In order to determine the intracellular efficiency and catalytic potential of the two selected SOFA-HDV Rz to target Pax-5B, Northern blot hybridization on Pax-5 negative 293T cells co-transfected with a recombinant Pax-5B construct and increasing amounts of SOFA-HDV Rz DNA (10, 100 and 1000 ng) were performed (Figure 3A). The insert encoding the ribozymes were cloned in a Pol III-driven vector (psiRNA hH1). An increasing reduction of the intracellular levels of human Pax-5B transcripts was observed concomitant to increasing amounts of transfected specific ribozymes in all cases (Figure 3A and B). The highest concentration of SOFA-HDV Rz yielded a decrease of the Pax-5B substrate over 50% (Figure 3B). Control samples including untreated 293T cells, empty expression vectors, and individual Pax-5B and SOFA-HDV Rz transfectants were also included to evaluate ribozyme catalytic activity (Figure 3A). Thereafter, the same blots were subsequently hybridized with a human actin probe (Figure 3A, lower panel) to demonstrate that the decreasing levels observed in Pax-5B transcript expression were in fact due to specific ribozyme cleavage and not a general outcome of messenger RNA degradation following treatment. Evidence shows that SOFA-HDV Rz are capable of cleaving their specific substrate in a dose-dependant manner in an intracellular environment. Finally, Northern blot hybridizations were also performed using a probe for the specific detection of the Pax-5A isoform and no variations of the mRNA level was detected in the presence of Pax-5B specific ribozymes (data not shown). The latter results also supported the notion that SOFA-HDV Rz do not elicit off-target cleavage. Figure 3.In vivo evaluation of genetically engineered SOFA-HDV Rz to suppress the expression levels of the human Pax-5B gene products. (A) Northern analysis were conducted on RNA extracts from 293T cells transiently cotransfected with Pax-5B (500 ng); increasing amounts of SOFA-HDV Rz (1, 100 and 1000 ng) and finally filler DNA to totalize 1.5 mug. Individual controls are indicated as the untransfected cells (293T); cells cotransfected with Pax-5B along with the SOFA-HDV Rz empty vector (identified Pax-5B); and cells cotransfected with SOFA-HDV Rz along with the Pax-5B empty vector (identified Rz). Radiolabeled RNA probes were then hybridized onto the membrane to reveal transcript expression levels from intracellular Pax-5B (top panel) and actin (bottom panel) as an internal reference. (B) The radioactivity from the hybridized Pax-5B probes was then calculated and normalized on actin transcripts densities using a radioanalytic scanner and plotted with error bars in relation to expression ratios (in black). SOFA-HDV Rz RNA levels are also plotted accordingly (right of the panel, in white). (C) Electrophorectic Mobility Shift Assays (EMSA) were conducted on nuclear extracts from 293T cells cotransfected with Pax-5B and SOFA-HDV Rz. Nuclear extracts were incubated with either with Pax-5 (top panel) or NF-kappaB-specific (bottom panel) dsDNA oligonucleotides labeled at the 5' end with [gamma-32P]. DNA-protein complexes were resolved and analyzed on a 4% polyacrylamide gel. Specific (S) and non-specific (NS) cold competition (Comp) assays were carried out by adding a 100-fold molar excess of unlabeled dsDNA oligonucleotides corresponding to the Pax-5 or the NF-kappaB consensus-binding motif. Control lanes were loaded with free probe (Probe) and extracts from untouched 293T cells (293T). Other controls include transfections of the Pax-5B empty vector (identified pcDNA), the Pax-5B expression vector (identified Pax-5B) and finally the SOFA-HDV Rz empty vector (identified psiRNA).
###end p 41
###begin p 42
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 127 128 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 230 232 230 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 436 439 435 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 440 442 439 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 495 498 494 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 499 501 498 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 560 563 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 564 566 563 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 718 721 717 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 722 724 721 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 788 791 787 790 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 830 836 829 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1098 1099 1097 1098 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1217 1220 1216 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1221 1223 1220 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1290 1295 1289 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 1402 1404 1393 1395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1659 1664 1650 1655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 1848 1851 1835 1838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1852 1854 1839 1841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1892 1895 1879 1882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1896 1898 1883 1885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1929 1935 1916 1922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 50 53 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 270 273 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 463 466 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 538 541 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1018 1021 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1233 1236 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1958 1961 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
In vivo evaluation of genetically engineered SOFA-HDV Rz to suppress the expression levels of the human Pax-5B gene products. (A) Northern analysis were conducted on RNA extracts from 293T cells transiently cotransfected with Pax-5B (500 ng); increasing amounts of SOFA-HDV Rz (1, 100 and 1000 ng) and finally filler DNA to totalize 1.5 mug. Individual controls are indicated as the untransfected cells (293T); cells cotransfected with Pax-5B along with the SOFA-HDV Rz empty vector (identified Pax-5B); and cells cotransfected with SOFA-HDV Rz along with the Pax-5B empty vector (identified Rz). Radiolabeled RNA probes were then hybridized onto the membrane to reveal transcript expression levels from intracellular Pax-5B (top panel) and actin (bottom panel) as an internal reference. (B) The radioactivity from the hybridized Pax-5B probes was then calculated and normalized on actin transcripts densities using a radioanalytic scanner and plotted with error bars in relation to expression ratios (in black). SOFA-HDV Rz RNA levels are also plotted accordingly (right of the panel, in white). (C) Electrophorectic Mobility Shift Assays (EMSA) were conducted on nuclear extracts from 293T cells cotransfected with Pax-5B and SOFA-HDV Rz. Nuclear extracts were incubated with either with Pax-5 (top panel) or NF-kappaB-specific (bottom panel) dsDNA oligonucleotides labeled at the 5' end with [gamma-32P]. DNA-protein complexes were resolved and analyzed on a 4% polyacrylamide gel. Specific (S) and non-specific (NS) cold competition (Comp) assays were carried out by adding a 100-fold molar excess of unlabeled dsDNA oligonucleotides corresponding to the Pax-5 or the NF-kappaB consensus-binding motif. Control lanes were loaded with free probe (Probe) and extracts from untouched 293T cells (293T). Other controls include transfections of the Pax-5B empty vector (identified pcDNA), the Pax-5B expression vector (identified Pax-5B) and finally the SOFA-HDV Rz empty vector (identified psiRNA).
###end p 42
###begin p 43
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 215 221 215 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 369 371 369 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 412 418 412 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 510 516 510 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 551 559 551 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">figure 3</xref>
###xml 622 628 622 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 809 815 809 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1044 1052 1040 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 97 100 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 381 384 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 833 836 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 852 855 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
In order to confirm the previous data, we then investigated the effect of mRNA reduction by SOFA-HDV Rz cleavage on protein expression levels. Since, there are no known anti-Pax-5B antibodies available, we analyzed Pax-5B protein levels via its DNA-binding activity by electrophoretic mobility shifts assays (EMSA). Using 293T cells co-transfected with recombinant Pax-5B and SOFA-HDV Rz plasmids, the levels of Pax-5B DNA-binding activity was measured using radiolabeled dsDNA consensus-binding sites for the Pax-5B transcription factor. As shown in figure 3C, a noticeable shifted complex in 293T expressing recombinant Pax-5B was observed while no protein-DNA complexes were detected in control samples (lanes Probe, 293T, pcDNA and psiRNA-hH1). More importantly, nuclear extracts from cells co-expressing Pax-5B with either SOFA-HDV Rz-B75 or SOFA-HDV Rz-B78, revealed a significant reduction in shifted complex intensity. Control EMSA experiments were also performed with the same nuclear extracts incubated with a radiolabeled NF-kappaB (Figure 3C, lower panel) DNA consensus-binding site. NF-kappaB binding efficiencies were not altered in any of the samples tested. Moreover, the shifted complexes in both assays were subjected to both specific and non-specific 100-fold excess cold competitions, thereby demonstrating the identity of the protein/DNA complexes.
###end p 43
###begin p 44
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 109 111 109 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 223 225 223 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 402 405 401 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 406 408 405 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 548 556 547 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 593 596 592 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 597 599 596 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 695 703 694 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 979 982 974 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 983 985 978 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1278 1281 1273 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1282 1284 1277 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1341 1350 1336 1345 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1350 1353 1345 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1354 1356 1349 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1542 1545 1537 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1546 1548 1541 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1635 1636 1630 1631 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1638 1641 1633 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1642 1644 1637 1639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1662 1663 1657 1658 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1696 1699 1691 1694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1700 1702 1695 1697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1350 2102 1345 2097 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="45"><italic>Pax</italic>-<italic>5B</italic> tailored SOFA- HDV Rz cleave their intracellular target substrate in a dose-dependent manner. Quantitative RT&#8211;PCR was performed on the 293-B2 cell line (293 HEK cells stably expressing <italic>Pax</italic>-<italic>5B</italic>) transiently transfected with increasing amounts of SOFA-HDV Rz-B75 DNA to determine (<bold>A</bold>) <italic>Pax</italic>-<italic>5B</italic> transcripts and (<bold>B</bold>) SOFA-HDV Rz expression levels. <italic>Pax</italic>-<italic>5B</italic> and SOFA-HDV Rz levels were normalized using HPRT mRNA and plotted in relation to the relative percentage of the control 293-B2 cell line. Control samples are also included being the 293-B2 cell line transfected with the SOFA-HDV Rz empty vector (identified psiRNA) and a non-specific SOFA-HDV Rz (identified NS Rz) were also tested. Error bars are indicative of two independent sets of experiments.</p>
###xml 1350 2102 1345 2097 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="45"><italic>Pax</italic>-<italic>5B</italic> tailored SOFA- HDV Rz cleave their intracellular target substrate in a dose-dependent manner. Quantitative RT&#8211;PCR was performed on the 293-B2 cell line (293 HEK cells stably expressing <italic>Pax</italic>-<italic>5B</italic>) transiently transfected with increasing amounts of SOFA-HDV Rz-B75 DNA to determine (<bold>A</bold>) <italic>Pax</italic>-<italic>5B</italic> transcripts and (<bold>B</bold>) SOFA-HDV Rz expression levels. <italic>Pax</italic>-<italic>5B</italic> and SOFA-HDV Rz levels were normalized using HPRT mRNA and plotted in relation to the relative percentage of the control 293-B2 cell line. Control samples are also included being the 293-B2 cell line transfected with the SOFA-HDV Rz empty vector (identified psiRNA) and a non-specific SOFA-HDV Rz (identified NS Rz) were also tested. Error bars are indicative of two independent sets of experiments.</p></caption>
###xml 2102 2102 2097 2097 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn432f4"/>
###xml 1341 2102 1336 2097 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="45"><italic>Pax</italic>-<italic>5B</italic> tailored SOFA- HDV Rz cleave their intracellular target substrate in a dose-dependent manner. Quantitative RT&#8211;PCR was performed on the 293-B2 cell line (293 HEK cells stably expressing <italic>Pax</italic>-<italic>5B</italic>) transiently transfected with increasing amounts of SOFA-HDV Rz-B75 DNA to determine (<bold>A</bold>) <italic>Pax</italic>-<italic>5B</italic> transcripts and (<bold>B</bold>) SOFA-HDV Rz expression levels. <italic>Pax</italic>-<italic>5B</italic> and SOFA-HDV Rz levels were normalized using HPRT mRNA and plotted in relation to the relative percentage of the control 293-B2 cell line. Control samples are also included being the 293-B2 cell line transfected with the SOFA-HDV Rz empty vector (identified psiRNA) and a non-specific SOFA-HDV Rz (identified NS Rz) were also tested. Error bars are indicative of two independent sets of experiments.</p></caption><graphic xlink:href="gkn432f4"/></fig>
###xml 31 34 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 357 360 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 639 642 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 898 901 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1232 1235 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1372 1375 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1606 1609 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1670 1673 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1712 1715 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1929 1932 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1993 1996 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
Next, we wanted to assess SOFA-HDV Rz activity in cells expressing physiological levels of intracellular Pax-5B substrates. To accomplish this, a 293-B2 cell clone which stably expresses the full coding region of human Pax-5B was generated. Subsequently, these cells were transiently transfected with increasing amounts of the most effective ribozyme, SOFA-HDV Rz-B75, (8 ng to 4 mug) and the level of Pax-5B mRNA was monitored by quantitative RT-PCR using primers amplifying a region spanning the 5'UTR and the first exon of the target substrate (Figure 4A). We observed a decrease of 76% in Pax-5B levels as intracellular levels of SOFA-HDV Rz-B75 increased following transfection treatments (Figure 4B). Conversely, no suppression was observed in control extract of 293-B2 cells transfected with 4 microg of either the expression vector alone (psiRNA-hH1) or with a non-specific functional SOFA-HDV Rz (NS Rz) containing a mismatched recognition motif unable to recognize the Pax-5B substrate. As expected, no ribozymes were detected in cells transfected with the empty vector alone, whereas increasing amounts of ribozyme expression was observed in other samples, which corroborated with the dose-response transfections of SOFA-HDV Rz in the 293-B2 cell line. The levels of Pax-5B were normalized in relation to the HPRT reference gene. Figure 4.Pax-5B tailored SOFA- HDV Rz cleave their intracellular target substrate in a dose-dependent manner. Quantitative RT-PCR was performed on the 293-B2 cell line (293 HEK cells stably expressing Pax-5B) transiently transfected with increasing amounts of SOFA-HDV Rz-B75 DNA to determine (A) Pax-5B transcripts and (B) SOFA-HDV Rz expression levels. Pax-5B and SOFA-HDV Rz levels were normalized using HPRT mRNA and plotted in relation to the relative percentage of the control 293-B2 cell line. Control samples are also included being the 293-B2 cell line transfected with the SOFA-HDV Rz empty vector (identified psiRNA) and a non-specific SOFA-HDV Rz (identified NS Rz) were also tested. Error bars are indicative of two independent sets of experiments.
###end p 44
###begin p 45
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 4 6 4 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 192 195 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 196 198 196 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 285 286 285 286 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 288 291 288 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 292 294 292 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 312 313 312 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 346 349 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 350 352 350 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 22 25 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 256 259 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 320 323 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 362 365 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 579 582 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 643 646 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
Pax-5B tailored SOFA- HDV Rz cleave their intracellular target substrate in a dose-dependent manner. Quantitative RT-PCR was performed on the 293-B2 cell line (293 HEK cells stably expressing Pax-5B) transiently transfected with increasing amounts of SOFA-HDV Rz-B75 DNA to determine (A) Pax-5B transcripts and (B) SOFA-HDV Rz expression levels. Pax-5B and SOFA-HDV Rz levels were normalized using HPRT mRNA and plotted in relation to the relative percentage of the control 293-B2 cell line. Control samples are also included being the 293-B2 cell line transfected with the SOFA-HDV Rz empty vector (identified psiRNA) and a non-specific SOFA-HDV Rz (identified NS Rz) were also tested. Error bars are indicative of two independent sets of experiments.
###end p 45
###begin p 46
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 155 161 155 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 313 319 313 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 394 400 394 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 573 579 569 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 230 233 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 480 483 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
Using nuclear protein extracts from the cell described above, we again analyzed Pax-5B DNA-binding suppression through EMSA analyses. We observed a strong Pax-5B shifted complex from 293-B2 nuclear extracts in the absence of SOFA-HDV Rz, while its presence led to a significant reduction of the amount of shifted Pax-5B complex (data not shown). Moreover, the shift was shown to be specific to Pax-5B protein since NF-kappaB DNA complexes did not vary in intensity following SOFA-HDV Rz transfections. Together, these data demonstrate that the intracellular suppression of Pax-5B expression is mediated through specific ribozyme activity which can be observed at both the transcriptional and translational levels.
###end p 46
###begin title 47
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 51 53 51 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
Ribozyme-mediated suppression decreases target Pax-5B mRNA stability in B lymphocytes
###end title 47
###begin p 48
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 102 104 102 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 337 339 337 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 504 507 504 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 508 510 508 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 570 578 570 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 745 748 745 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 749 751 749 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 869 872 869 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 873 875 873 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1147 1153 1147 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 1248 1254 1248 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1279 1285 1279 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 1293 1301 1293 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1358 1364 1358 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1393 1399 1393 1399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 1444 1450 1444 1450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1504 1509 1504 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 1525 1531 1525 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 1534 1543 1534 1543 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1564 1567 1564 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1568 1570 1568 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1606 1609 1606 1609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1610 1612 1610 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1743 1746 1743 1746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1747 1749 1747 1749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1902 1903 1902 1903 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1905 1911 1905 1911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 1927 1933 1927 1933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1957 1958 1957 1958 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2015 2018 2015 2018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 2019 2021 2019 2021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 2262 2263 2262 2263 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2275 2276 2275 2276 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2278 2281 2278 2281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 2282 2284 2282 2284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1543 2748 1543 2747 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="49">SOFA-HDV Rz decrease <italic>Pax</italic>-<italic>5B</italic> intracellular levels by increasing <italic>Pax</italic>-<italic>5B</italic> mRNA decay rates in B lymphocytes. The REH B-cell line was stably transfected with either the empty vector (identified psiRNA) or <italic>Pax</italic>-<italic>5B</italic> specific SOFA-HDV Rz-B75 and antibiotic resistant clones were selected (clones 1, 2, 3 and mix populations). Quantitative RT&#8211;PCR was then performed on (<bold>A</bold>) <italic>Pax-5A</italic> (in white) and <italic>Pax-5B</italic> (in black) as well as (<bold>B</bold>) SOFA-HDV Rz expression levels in each cell population. <italic>Pax</italic>-<italic>5B</italic> and Rz transcript levels were normalized using the HPRT reference mRNA and plotted in relation to the percentage of their respective transcript levels (except for the Rz) in the non-transfected REH parental cell line. mRNA decay rates for (<bold>C</bold>) HPRT and (<bold>D</bold>) <italic>Pax</italic>-<italic>5B</italic> were also analyzed by quantitative RT-PCR and compared in time (hours) between REH (square symbols/solid line) cell clones stably transfected with psiRNA (circle symbols/solid line) and the SOFA-HDV Rz-B75 (circle symbols/dotted line) following actinomycin D (2 &#956;M) treatment. The transcript half-life was then calculated in percentage ratio to respective mRNA levels in untreated cell clones and plotted error bars are indicative of two independent experiments.</p>
###xml 1543 2748 1543 2747 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="49">SOFA-HDV Rz decrease <italic>Pax</italic>-<italic>5B</italic> intracellular levels by increasing <italic>Pax</italic>-<italic>5B</italic> mRNA decay rates in B lymphocytes. The REH B-cell line was stably transfected with either the empty vector (identified psiRNA) or <italic>Pax</italic>-<italic>5B</italic> specific SOFA-HDV Rz-B75 and antibiotic resistant clones were selected (clones 1, 2, 3 and mix populations). Quantitative RT&#8211;PCR was then performed on (<bold>A</bold>) <italic>Pax-5A</italic> (in white) and <italic>Pax-5B</italic> (in black) as well as (<bold>B</bold>) SOFA-HDV Rz expression levels in each cell population. <italic>Pax</italic>-<italic>5B</italic> and Rz transcript levels were normalized using the HPRT reference mRNA and plotted in relation to the percentage of their respective transcript levels (except for the Rz) in the non-transfected REH parental cell line. mRNA decay rates for (<bold>C</bold>) HPRT and (<bold>D</bold>) <italic>Pax</italic>-<italic>5B</italic> were also analyzed by quantitative RT-PCR and compared in time (hours) between REH (square symbols/solid line) cell clones stably transfected with psiRNA (circle symbols/solid line) and the SOFA-HDV Rz-B75 (circle symbols/dotted line) following actinomycin D (2 &#956;M) treatment. The transcript half-life was then calculated in percentage ratio to respective mRNA levels in untreated cell clones and plotted error bars are indicative of two independent experiments.</p></caption>
###xml 2748 2748 2747 2747 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn432f5"/>
###xml 1534 2748 1534 2747 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="49">SOFA-HDV Rz decrease <italic>Pax</italic>-<italic>5B</italic> intracellular levels by increasing <italic>Pax</italic>-<italic>5B</italic> mRNA decay rates in B lymphocytes. The REH B-cell line was stably transfected with either the empty vector (identified psiRNA) or <italic>Pax</italic>-<italic>5B</italic> specific SOFA-HDV Rz-B75 and antibiotic resistant clones were selected (clones 1, 2, 3 and mix populations). Quantitative RT&#8211;PCR was then performed on (<bold>A</bold>) <italic>Pax-5A</italic> (in white) and <italic>Pax-5B</italic> (in black) as well as (<bold>B</bold>) SOFA-HDV Rz expression levels in each cell population. <italic>Pax</italic>-<italic>5B</italic> and Rz transcript levels were normalized using the HPRT reference mRNA and plotted in relation to the percentage of their respective transcript levels (except for the Rz) in the non-transfected REH parental cell line. mRNA decay rates for (<bold>C</bold>) HPRT and (<bold>D</bold>) <italic>Pax</italic>-<italic>5B</italic> were also analyzed by quantitative RT-PCR and compared in time (hours) between REH (square symbols/solid line) cell clones stably transfected with psiRNA (circle symbols/solid line) and the SOFA-HDV Rz-B75 (circle symbols/dotted line) following actinomycin D (2 &#956;M) treatment. The transcript half-life was then calculated in percentage ratio to respective mRNA levels in untreated cell clones and plotted error bars are indicative of two independent experiments.</p></caption><graphic xlink:href="gkn432f5"/></fig>
###xml 121 124 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 317 320 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1269 1272 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1329 1332 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1548 1551 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1764 1767 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1965 1968 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 2480 2483 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
In order to investigate the gene suppression activities of the ribozyme on endogenously expressed Pax-5B, again the SOFA-HDV Rz-B75 construct was stably transfected in the REH B-cell line. Zeocin-resistant clones as well as a mixed population of transfectants were then analyzed by quantitative RT-PCR to assess SOFA-HDV Rz-mediated Pax-5B suppression. All amplified elements were normalized to HPRT expression. Stably transfected cell clones demonstrated a marked suppression up to 79% (clone B75-3) of Pax-5B mRNA levels in comparison with the parental REH cell line (Figure 5A). These REH B75 cell clones were also compared with a REH cell population stably transfected with the empty vector alone (psiRNA-hH1), which did not demonstrate any Pax-5B suppression activity when compared with the control parental REH cell line. The fact that Rz-mediated suppression of Pax-5B was observed in all screened REH B75 cell clones and in the mixed population of transfected cells demonstrates the consistent activity of the ribozyme in a B lymphocyte intracellular environment and rules out a clonal effect. Stable REH B75 clones were also analyzed for Pax-5A expression by real-time PCR. As predicted, we observed no cross-reactive suppression from our Pax-5B-specific SOFA-HDV Rz on Pax-5A mRNAs (Figure 5A). Interestingly, the SOFA-HDV Rz-mediated knockdown of Pax-5B resulted in an induction of Pax-5A mRNA expression. These results suggest that Pax-5B plays a negative role in the trans-activity of other Pax-5 isoforms (i.e. Pax-5A). Figure 5.SOFA-HDV Rz decrease Pax-5B intracellular levels by increasing Pax-5B mRNA decay rates in B lymphocytes. The REH B-cell line was stably transfected with either the empty vector (identified psiRNA) or Pax-5B specific SOFA-HDV Rz-B75 and antibiotic resistant clones were selected (clones 1, 2, 3 and mix populations). Quantitative RT-PCR was then performed on (A) Pax-5A (in white) and Pax-5B (in black) as well as (B) SOFA-HDV Rz expression levels in each cell population. Pax-5B and Rz transcript levels were normalized using the HPRT reference mRNA and plotted in relation to the percentage of their respective transcript levels (except for the Rz) in the non-transfected REH parental cell line. mRNA decay rates for (C) HPRT and (D) Pax-5B were also analyzed by quantitative RT-PCR and compared in time (hours) between REH (square symbols/solid line) cell clones stably transfected with psiRNA (circle symbols/solid line) and the SOFA-HDV Rz-B75 (circle symbols/dotted line) following actinomycin D (2 muM) treatment. The transcript half-life was then calculated in percentage ratio to respective mRNA levels in untreated cell clones and plotted error bars are indicative of two independent experiments.
###end p 48
###begin p 49
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 25 27 25 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 67 69 67 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 200 203 200 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 204 206 204 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 359 360 359 360 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 362 368 362 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 414 415 414 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 472 475 472 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 476 478 476 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 719 720 719 720 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 732 733 732 733 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 735 738 735 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 739 741 739 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 5 8 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 221 224 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 422 425 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 937 940 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
SOFA-HDV Rz decrease Pax-5B intracellular levels by increasing Pax-5B mRNA decay rates in B lymphocytes. The REH B-cell line was stably transfected with either the empty vector (identified psiRNA) or Pax-5B specific SOFA-HDV Rz-B75 and antibiotic resistant clones were selected (clones 1, 2, 3 and mix populations). Quantitative RT-PCR was then performed on (A) Pax-5A (in white) and Pax-5B (in black) as well as (B) SOFA-HDV Rz expression levels in each cell population. Pax-5B and Rz transcript levels were normalized using the HPRT reference mRNA and plotted in relation to the percentage of their respective transcript levels (except for the Rz) in the non-transfected REH parental cell line. mRNA decay rates for (C) HPRT and (D) Pax-5B were also analyzed by quantitative RT-PCR and compared in time (hours) between REH (square symbols/solid line) cell clones stably transfected with psiRNA (circle symbols/solid line) and the SOFA-HDV Rz-B75 (circle symbols/dotted line) following actinomycin D (2 muM) treatment. The transcript half-life was then calculated in percentage ratio to respective mRNA levels in untreated cell clones and plotted error bars are indicative of two independent experiments.
###end p 49
###begin p 50
###xml 377 385 377 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 460 463 460 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 464 466 464 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 593 599 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 49 52 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 249 252 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
Clones of REH cells stably transfected with SOFA-HDV Rz-B75 were then subjected to quantitative RT-PCR analysis to examine ribozyme expression in every REH clone in comparison to the REH parental cell line. Relatively high expression levels of SOFA-HDV Rz were observed in every cell population except for REH cells stably transfected with the empty vector (psiRNA-hH1) alone (Figure 5B). Since the REH B75-3 cell clone demonstrated the highest attenuation in Pax-5B levels, this latter cell clone was used in subsequent cellular and molecular analyses for the functional investigation of the Pax-5B gene product.
###end p 50
###begin p 51
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 48 50 48 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 134 136 134 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 705 713 704 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1075 1078 1074 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1079 1081 1078 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1182 1185 1181 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1186 1188 1185 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1305 1313 1304 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1332 1335 1331 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1336 1338 1335 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1549 1552 1548 1551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1553 1555 1552 1554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1830 1833 1829 1832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 1834 1836 1833 1835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 1901 1904 1900 1903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax</italic>
###xml 68 71 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 160 163 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 531 534 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1243 1246 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1771 1774 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
Initially, the specific mRNA decay rates of Pax-5B targeted by SOFA-HDV Rz in the REH cell line were examined. More specifically, Pax-5B mRNA stability in SOFA-HDV Rz-B75 bearing REH cells was monitored and compared with control cell populations (REH and REH/psiRNA-hH1) in time following a treatment of 2 muM actinomycin-D to inhibit mRNA synthesis. This was done to verify whether or not there were any differences in global transcript decay rates between the REH parental cell line and REH transfectants (psiRNA-hH1 or the SOFA-HDV Rz-B75). For this experiment, relative amounts of the HPRT mRNA from the different cell line clones were analyzed at various time points by quantitative RT-PCR analysis (Figure 5C). Following actinomycin-D treatment, a steady decline of HPRT transcripts was registered up to 12 h and these decay rates were identical in all cell lines tested. The half-lives of HPRT mRNA were calculated according to the slope which represented 2.9, 2.2 and 2.6 h for the REH, REH/psiRNA-hH1 and REH B75 cell lines, respectively. However, in the case where Pax-5B degradation rates were plotted in time following actinomycin-D treatment, a significant decrease in Pax-5B stability was observed in B cells containing the SOFA-HDV Rz-B75 construct in comparison to the control cell lines (Figure 5D). Interestingly, Pax-5B mRNA levels in the REH B75 clones were nearly undetectable after only 4 h of treatment, whereas these transcripts could still be observed up to 14 h in the other control cell lines (REH and REH/psiRNA-hH1. The Pax-5B mRNA half-life in REH B cells was calculated at 3.2, 3.3 and 0.7 h for the REH, REH/psiRNA-hH1 and REH B75 cell lines, respectively. These results strongly suggest that this suppression occurs through specific SOFA-HDV Rz activity which accelerates 4-fold the intracellular Pax-5B transcript degradation, which, in turn, leads to a reduction in Pax-5B protein activity.
###end p 51
###begin title 52
###xml 10 16 10 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human Pax-5B transcriptional element negatively regulates CD19 expression
###end title 52
###begin p 53
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 198 204 198 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 293 299 293 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 367 375 367 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 457 463 457 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 704 712 704 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 779 783 779 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 901 905 901 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1007 1011 1007 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1339 1347 1339 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1397 1401 1397 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1491 1495 1491 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1530 1536 1530 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1613 1619 1613 1619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1667 1671 1667 1671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1690 1699 1690 1699 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 1699 1705 1699 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1753 1757 1753 1757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1781 1782 1781 1782 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1893 1897 1893 1897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1931 1935 1931 1935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 2027 2031 2027 2031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 2150 2151 2150 2151 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2217 2221 2217 2221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1699 2545 1699 2545 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="54"><italic>Pax-5B</italic> is a negative transcriptional regulator of the <italic>CD19</italic> cell surface antigen. (<bold>A</bold>) Quantitative RT&#8211;PCR was conducted on extracts from the REH, the psiRNA-hH1 and the B75 cell clones to reveal <italic>CD19</italic> intracellular transcript levels. <italic>CD19</italic> mRNA values were normalized using HPRT levels and plotted in relation to the percentage of <italic>CD19</italic> expression levels of the parental untreated REH cell line. Error bars are indicative of two independent experiments. (<bold>B</bold>) The cells were evaluated for cell surface protein expression of <italic>CD19</italic> (left panels) and HLA-DR (right panels) using cell-flow cytometry. The plotted fluorescence from the direct labeling of the specific antibodies (empty graphs) is overlaid on the non-specific signal from the control isotype matched antibodies (solid graphs). The presented data represents one of two independent experiments.</p>
###xml 1699 2545 1699 2545 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="54"><italic>Pax-5B</italic> is a negative transcriptional regulator of the <italic>CD19</italic> cell surface antigen. (<bold>A</bold>) Quantitative RT&#8211;PCR was conducted on extracts from the REH, the psiRNA-hH1 and the B75 cell clones to reveal <italic>CD19</italic> intracellular transcript levels. <italic>CD19</italic> mRNA values were normalized using HPRT levels and plotted in relation to the percentage of <italic>CD19</italic> expression levels of the parental untreated REH cell line. Error bars are indicative of two independent experiments. (<bold>B</bold>) The cells were evaluated for cell surface protein expression of <italic>CD19</italic> (left panels) and HLA-DR (right panels) using cell-flow cytometry. The plotted fluorescence from the direct labeling of the specific antibodies (empty graphs) is overlaid on the non-specific signal from the control isotype matched antibodies (solid graphs). The presented data represents one of two independent experiments.</p></caption>
###xml 2545 2545 2545 2545 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn432f6"/>
###xml 1690 2545 1690 2545 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="54"><italic>Pax-5B</italic> is a negative transcriptional regulator of the <italic>CD19</italic> cell surface antigen. (<bold>A</bold>) Quantitative RT&#8211;PCR was conducted on extracts from the REH, the psiRNA-hH1 and the B75 cell clones to reveal <italic>CD19</italic> intracellular transcript levels. <italic>CD19</italic> mRNA values were normalized using HPRT levels and plotted in relation to the percentage of <italic>CD19</italic> expression levels of the parental untreated REH cell line. Error bars are indicative of two independent experiments. (<bold>B</bold>) The cells were evaluated for cell surface protein expression of <italic>CD19</italic> (left panels) and HLA-DR (right panels) using cell-flow cytometry. The plotted fluorescence from the direct labeling of the specific antibodies (empty graphs) is overlaid on the non-specific signal from the control isotype matched antibodies (solid graphs). The presented data represents one of two independent experiments.</p></caption><graphic xlink:href="gkn432f6"/></fig>
###xml 264 267 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1607 1612 <span type="species:ncbi:9606">human</span>
A different variant, Pax-5A (BSAP), has been consistently associated as a transcriptional activator of the CD19 surface antigen and therefore we set out to evaluate the transactivation potential of Pax-5B on CD19 expression. Using REH cells stably expressing SOFA-HDV Rz-B75, the influence of Pax-5B on CD19 mRNA expression were assessed through quantitative RT-PCR (Figure 6A). Unexpectedly, we observed a 3.6-fold induction of CD19 mRNA expression in the Pax-5B suppressed REH cell line when compared to both control cell populations (REH parental and the psiRNA-hH1 transfected cells). To confirm this finding, we measured the cell surface expression of the CD19 protein in the same REH cell systems (Figure 6B). Using flow cytometry, we were able to detect expression of the CD19 antigen in all B cells tested. Concomitant to mRNA levels, the REH B75 cells expressed higher levels of cell surface CD19 up to 6-fold over the REH parental cell line. In order to properly demonstrate that the induction of CD19 surface expression was not a result of a generalized increase in total cell surface receptors, the expression of a cell surface major histocompatibility complex class II element (HLA-DR) was examined on all three cellular settings. We found no variation in the expression of cell surface HLA-DR in all cell populations tested (Figure 6B). As a further confirmation, flow cytometry for CD19 expression was also performed on other REH B75-1 and -2 clones and again, an increase in CD19 expression was observed following Pax-5B suppression (data not shown). These results strongly suggest that the human Pax-5B protein negatively regulates the expression of CD19 in B lymphocytes. Figure 6.Pax-5B is a negative transcriptional regulator of the CD19 cell surface antigen. (A) Quantitative RT-PCR was conducted on extracts from the REH, the psiRNA-hH1 and the B75 cell clones to reveal CD19 intracellular transcript levels. CD19 mRNA values were normalized using HPRT levels and plotted in relation to the percentage of CD19 expression levels of the parental untreated REH cell line. Error bars are indicative of two independent experiments. (B) The cells were evaluated for cell surface protein expression of CD19 (left panels) and HLA-DR (right panels) using cell-flow cytometry. The plotted fluorescence from the direct labeling of the specific antibodies (empty graphs) is overlaid on the non-specific signal from the control isotype matched antibodies (solid graphs). The presented data represents one of two independent experiments.
###end p 53
###begin p 54
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 82 83 82 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 328 332 328 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 451 452 451 452 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 518 522 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
Pax-5B is a negative transcriptional regulator of the CD19 cell surface antigen. (A) Quantitative RT-PCR was conducted on extracts from the REH, the psiRNA-hH1 and the B75 cell clones to reveal CD19 intracellular transcript levels. CD19 mRNA values were normalized using HPRT levels and plotted in relation to the percentage of CD19 expression levels of the parental untreated REH cell line. Error bars are indicative of two independent experiments. (B) The cells were evaluated for cell surface protein expression of CD19 (left panels) and HLA-DR (right panels) using cell-flow cytometry. The plotted fluorescence from the direct labeling of the specific antibodies (empty graphs) is overlaid on the non-specific signal from the control isotype matched antibodies (solid graphs). The presented data represents one of two independent experiments.
###end p 54
###begin title 55
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
Pax-5B suppression increases B-cell susceptibility to apoptotic events
###end title 55
###begin p 56
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 197 203 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 518 526 518 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 555 561 555 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 796 804 796 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 978 984 978 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1241 1247 1241 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1328 1337 1328 1337 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7.</label>
###xml 1337 1343 1337 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1405 1406 1405 1406 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1684 1685 1684 1685 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1337 2038 1337 2038 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="57"><italic>Pax-5B</italic> promotes REH cell survival by suppressing apoptotic events. (<bold>A</bold>) Cellular viability was evaluated in time (hours) in the B75 (dotted line) and the control psiRNA-hH1 cell (solid line) clones and plotted in relation to the percentage of cell growth events from the REH parental cell line using a colorimetric test (Cell titer Blue/Promega). (<bold>B</bold>) In the same microplates, cells were then submitted to the analysis of cellular apoptotic events through the evaluation of CASPASE 3/7 activity (Apo-ONE/Promega). Cellular apoptosis for each cell clone was then plotted in fold induction over the events measured in the REH parental cell line. Error bars are indicative of three independent experiments.</p>
###xml 1337 2038 1337 2038 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="57"><italic>Pax-5B</italic> promotes REH cell survival by suppressing apoptotic events. (<bold>A</bold>) Cellular viability was evaluated in time (hours) in the B75 (dotted line) and the control psiRNA-hH1 cell (solid line) clones and plotted in relation to the percentage of cell growth events from the REH parental cell line using a colorimetric test (Cell titer Blue/Promega). (<bold>B</bold>) In the same microplates, cells were then submitted to the analysis of cellular apoptotic events through the evaluation of CASPASE 3/7 activity (Apo-ONE/Promega). Cellular apoptosis for each cell clone was then plotted in fold induction over the events measured in the REH parental cell line. Error bars are indicative of three independent experiments.</p></caption>
###xml 2038 2038 2038 2038 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn432f7"/>
###xml 1328 2038 1328 2038 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F7" position="float"><label>Figure 7.</label><caption><p textid="57"><italic>Pax-5B</italic> promotes REH cell survival by suppressing apoptotic events. (<bold>A</bold>) Cellular viability was evaluated in time (hours) in the B75 (dotted line) and the control psiRNA-hH1 cell (solid line) clones and plotted in relation to the percentage of cell growth events from the REH parental cell line using a colorimetric test (Cell titer Blue/Promega). (<bold>B</bold>) In the same microplates, cells were then submitted to the analysis of cellular apoptotic events through the evaluation of CASPASE 3/7 activity (Apo-ONE/Promega). Cellular apoptosis for each cell clone was then plotted in fold induction over the events measured in the REH parental cell line. Error bars are indicative of three independent experiments.</p></caption><graphic xlink:href="gkn432f7"/></fig>
###xml 370 373 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1235 1240 <span type="species:ncbi:9606">human</span>
Previous studies have shown that both Pax-5 and CD19 are important regulatory components in B-cell proliferation and differentiation (25,26), therefore we sought to determine if the suppression of Pax-5B expression would impact cell growth and apoptosis in B lymphocytes. Cellular metabolic activities were thus examined in time for REH cells stably expressing the SOFA-HDV Rz-B75 in comparison with the REH parental and the vector-transfected control. Initially, the various cell lines proliferated at similar rates (Figure 7A). However, after 72 h, the Pax-5B attenuated REH cells ceased to proliferate. To assess the cause of this growth arrest, we determined cell death events in these cell lines using a microscale procedure to measure the activity of apoptosis effectors, CASPASES 3 and 7 (Figure 7B). We detected no significant apoptosis activity in the control REH cells (REH and vector-transfected) up to 168 h (7 days) of growth in appropriate conditions. Conversely, Pax-5B-suppressed cells initiated apoptotic signaling cascades after 72 h. The onset of apoptotic events observed in the REH B75 cell line correlated with the proliferation arrest observed after 72 h. To our knowledge, this is the first indication that the human Pax-5B transcriptional element is involved in the cell fate outcomes of B lymphocytes. Figure 7.Pax-5B promotes REH cell survival by suppressing apoptotic events. (A) Cellular viability was evaluated in time (hours) in the B75 (dotted line) and the control psiRNA-hH1 cell (solid line) clones and plotted in relation to the percentage of cell growth events from the REH parental cell line using a colorimetric test (Cell titer Blue/Promega). (B) In the same microplates, cells were then submitted to the analysis of cellular apoptotic events through the evaluation of CASPASE 3/7 activity (Apo-ONE/Promega). Cellular apoptosis for each cell clone was then plotted in fold induction over the events measured in the REH parental cell line. Error bars are indicative of three independent experiments.
###end p 56
###begin p 57
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 68 69 68 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 347 348 347 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Pax-5B promotes REH cell survival by suppressing apoptotic events. (A) Cellular viability was evaluated in time (hours) in the B75 (dotted line) and the control psiRNA-hH1 cell (solid line) clones and plotted in relation to the percentage of cell growth events from the REH parental cell line using a colorimetric test (Cell titer Blue/Promega). (B) In the same microplates, cells were then submitted to the analysis of cellular apoptotic events through the evaluation of CASPASE 3/7 activity (Apo-ONE/Promega). Cellular apoptosis for each cell clone was then plotted in fold induction over the events measured in the REH parental cell line. Error bars are indicative of three independent experiments.
###end p 57
###begin title 58
DISCUSSION
###end title 58
###begin p 59
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 224 230 224 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 235 241 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 428 433 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 631 637 631 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 642 648 642 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1379 1384 1379 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 1489 1495 1489 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1528 1533 <span type="species:ncbi:9606">human</span>
Many recent studies have contributed to the better understanding of general Pax-5 function in various biological processes (5,6); however, few have attempted to discriminate between the physiological roles of the individual Pax-5A and Pax-5B variants. The inherent difficulty is largely due to the fact that both genes and proteins are nearly identical differing only by their first exon. Most studies that examined the role of Pax-5 have relied mainly on antibodies (27,28), nucleic probes (29,30), RNAi (31), antisense oligonucleotides (32) and/or site-directed genetic alteration (33) that target common regions present in both Pax-5A and Pax-5B. It is, therefore, not possible to draw conclusions on the specific roles of the individual genes and/or proteins from these previous works. Recently, the development of gene inactivation tools has focused on the attenuation or silencing of target mRNA for the study of gene function. Reliable and selective gene suppression systems are a valuable tool to create loss and gain of function models which provide new insights for intracellular signaling discovery and pathway analysis. In this context, the findings of this study are significant. Here, we validate a novel gene-suppression system based on a genetically modified viral ribozyme for the functional characterization of highly similar gene products transcribed from the Pax-5 gene locus. This new gene-silencing approach has allowed us to reveal the important contribution of the Pax-5B gene during apoptotic events in human B lymphocytes.
###end p 59
###begin p 60
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 584 590 584 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 625 633 625 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 638 645 638 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 653 659 653 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 795 801 795 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 892 898 892 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 951 956 951 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 967 973 967 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 1025 1031 1025 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1076 1082 1076 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1135 1140 1135 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 1272 1277 1272 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 1318 1320 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 1321 1323 1321 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1500 1506 1500 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1601 1607 1601 1607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 37 40 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 139 142 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 524 527 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 578 583 <span type="species:ncbi:9606">human</span>
###xml 674 677 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1392 1395 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1560 1563 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
We have recently modified the native HDV Rz by the addition of a biosensor for the recognition of its specific substrate (18,19). The SOFA-HDV Rz is the only RNA-based gene suppression system of its kind to function as a riboswitch and therefore cleave only when the specific target mRNA is present. It has been shown previously that most Pax-5 expressing cells simultaneously produce multiple Pax-5 isoforms (11,20,34). Therefore, to study the unique contributions of the different gene products, we developed several SOFA-HDV Rz designed to target unique regions found in the human Pax-5B exon 1 mRNA sequence. When tested in vitro and in vivo, these Pax-5B specific SOFA-HDV Rz displayed a high level of target specificity. In all assays, we observed specific recognition and cleavage of the Pax-5B substrate with no suppressive off-target effects on the levels of the other major isoform Pax-5A. More interestingly, in B lymphocytes co-expressing Pax-5 isoforms, Pax-5A mRNA expression levels were up-regulated following Pax-5B down-regulation. These results suggest that Pax-5B plays a negative role in the transactivity of other Pax-5 isoforms. These observations are not surprising given the fact that autoregulation and negative transregulation activities between Pax-5 variants have been previously reported (35,36). As a control, we also designed a functional yet non-specific SOFA-HDV Rz and when tested in similar conditions, our results show that this ribozyme does not affect levels of Pax-5B RNA. Furthermore, the catalytic activity of the SOFA-HDV Rz was not cell-type dependent since Pax-5B transcript cleavage was observed in both HEK 293 and REH cells lines.
###end p 60
###begin p 61
###xml 193 199 193 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1019 1021 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 178 181 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 329 332 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 419 422 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 595 598 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
It is important to note that substrate cleavage occurs via direct ribozyme activity and is not mediated by RNA interference since the longest complementary region between a SOFA-HDV Rz and its Pax-5B substrate is 12 bp. We further ruled out the involvment of RNAi pathway components by gene expression analysis of mRNA from SOFA-HDV Rz transfected cells which revealed no activity from any RNAi elements following SOFA-HDV Rz mediated cleavage of a specific substrate (unpublished data; F. Briere, M. Laflamme, J.P. Perreault and R. Ouellette). The dose-dependent catalytic activity of the SOFA-HDV Rz observed in our transient co-transfections was not as pronounced when studying transfected B lymphocytes. In certain cases using B lymphocytes, the highest level of gene expression knock-down was observed in transfected clones with lower cellular concentration of ribozyme expression. These observations may be due to substrate accessibility and competition between promoter elements in our co-transfection settings (23,37).
###end p 61
###begin p 62
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 69 75 69 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 324 330 324 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 528 534 524 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 701 707 697 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 735 743 731 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 871 877 867 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 940 946 936 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1076 1082 1072 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1143 1149 1139 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1192 1198 1188 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1387 1393 1383 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 829 832 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 1479 1482 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
The reduction of Pax-5B transcript levels had a subsequent effect on Pax-5B protein levels which was most likely due to decreases in synthesis levels. Our findings using EMSA assays revealed that ribozyme-mediated gene silencing led to a concomitant attenuation of the target protein expression as observed by a decrease in Pax-5B DNA-binding activity. This reduced binding was not associated with a general decrease in DNA-binding activity as revealed by NF-kappaB control experiments. Our findings suggest that high levels of Pax-5B suppression are incompatible with survival of B cells (REH). Following selection of stably-transfected REH clones, the maximum level ribozyme-mediated suppression of Pax-5B was 85% of control cells. (Figure 5A). Despite numerous attempts, we were unable to identify any stably-transfected SOFA-HDV Rz clones with a greater reduction of Pax-5B expression. These findings are consistent with our results of Pax-5B knock-down experiments using RNAi (unpublished data; Robichaud, G.A. and R. Ouellette). In these experiments, we found that with Pax-5B-directed RNAi sequences we were able to completely suppress Pax-5B expression. However, total suppression of Pax-5B led to complete cell death of REH cells compared to control REH cells that received a scrambled RNAi sequence. Taken together, these results strongly suggest that a minimal requirement of Pax-5B expression is required for cell survival. It also reveals the usefulness of the SOFA-HDV Rz system as a tool to selectively suppress and study vital cellular elements.
###end p 62
###begin p 63
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 189 195 189 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 366 370 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 512 516 512 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 571 577 571 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 630 636 630 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 664 668 664 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 732 738 732 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 742 746 742 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 797 801 797 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1023 1027 1023 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1236 1238 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1239 1241 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1279 1283 1279 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1361 1363 1361 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 1364 1366 1364 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 1391 1395 1391 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1464 1470 1464 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
We then used our Pax-5B-attenuated B-cell system to study the effects on a known downstream target of Pax-5A, in this case, the CD19 gene. In previous studies, the DNA-binding motif of the Pax-5A protein or BSAP has been shown to bind the CD19 promoter region via a cluster of proximal Pax-5 recognition sites (7). Subsequently, this protein-DNA interaction induces CD19 gene expression which acts as a developmental checkpoint for early B-lineage commitment (38). Surprisingly, we observed a marked increase in CD19 expression both at the mRNA and protein levels in our Pax-5B knockdown B cells which, taken together, imply that Pax-5B is a negative regulator of CD19. This finding is contrary to the positive regulatory effect of Pax-5A on CD19 observed in previous studies (37). Interestingly, CD19 is a key molecule in the B lymphocyte signal transduction complex, where it associates with other proteins including the B-cell antigen complex (BCR) which has been shown to regulate B-cell fate and function (25,26). The CD19 surface protein modulates basal signaling thresholds and accelerates BCR signals thus serving as a general 'rheostat' that defines downstream signaling critical for B-cell responses, growth and autoimmunity (26,39). Furthermore, in certain instances, CD19 has also been shown to attenuate B-cell activation and proliferation events (40,41). It is precisely these CD19 events that could explain the lower proliferation rates observed in Pax-5B attenuated B lymphocytes.
###end p 63
###begin p 64
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5A</italic>
###xml 135 141 135 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 254 260 254 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 809 814 809 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 998 999 998 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1000 1002 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 1031 1037 1031 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 1220 1226 1220 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1228 1230 1228 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1268 1273 1268 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 81 86 <span type="species:ncbi:9606">human</span>
Previous studies have also demonstrated that a decrease in the expression of the human Pax-5 gene (with no discrimination to Pax-5A or Pax-5B) is associated with decreased B-cell growth rates (28,32). In addition to the lower proliferation rates seen in Pax-5B knockdown cells, we observed that these B lymphocytes undergo apoptotic events that are mediated through the activity of CASPASES 3\7. Apoptosis is a key cellular pathway that mitigates the production of defective cells that occur during aberrant cellular processes such as hypersensitivity, autoimmunity, infection, mutation, anergy and oncogenesis (42). Apoptosis is particularly important during the development of lymphocytes when it removes both ineffective and potentially harmful cells via the withdrawal of survival signals. Interestingly, Pax-5 expression has been primarily associated with the development and maintenance of B-cell progenitors, then subsequently decreases and ceases in terminally differentiated plasma cells (4,43). Our findings suggest that Pax-5B may be closely involved in the differentiation checkpoints that ensure the precise regulation of the development and proliferation programs. This is consistent with data from Rahman et al. (28), which show that the suppression of Pax-5 results in the growth arrest of pre-B cells-results that were not observed in either pro-B or mature B-cell lines.
###end p 64
###begin p 65
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 288 293 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 405 410 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 621 627 621 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5B</italic>
###xml 761 766 761 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
Apoptosis also plays a role in the prevention of oncogenic transformation associated with the development of cancer. Numerous studies have shown that aberrant expression of Pax-5 has been associated with the onset of different types of cancers (3,44), whereas others have also shown that Pax-5 is overexpressed in many types of B cell lymphoma and lymphocytic leukemia (20,30). Therefore, it appears that Pax-5 gene products are responsible on the one hand for the promotion B-cell commitment, and on the other, for the homeostasis of cell fate events. As a key switch in the balance between proliferation and apoptosis, Pax-5B could represent a potential target for therapeutic intervention. Further analysis of other downstream cell-fate regulators and known Pax-5 pathway components [i.e. p53 (45), Ets-1 (46), PD-1 (38) etc.] will help elucidate the complex networks and cell-fate events involved in B-cell development and oncogenesis. We are presently addressing some of these issues.
###end p 65
###begin p 66
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax-5</italic>
###xml 616 619 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
More recently, we and others have newly identified and characterized Pax-5 isoforms which result from the alternative splicing of the Pax-5 coding regions (20,34). On a functional basis, these protein variants possess different transactivation potential and have the ability to interact with different protein partners, and in certain cases, specific Pax-5 isoforms have been correlated with different types of cancers (20,47). These findings begin to address the complexity of the Pax-5 transcript and protein isoform function in B lymphocytes. Through the use of isoform-specific gene-silencing tools such as SOFA-HDV Rz, we are now able to better interrogate these regulators involved in B-cell development, cell-fate events and oncogenesis.
###end p 66
###begin title 67
ACKNOWLEDGEMENTS
###end title 67
###begin p 68
The work in the laboratory of JPP was supported by a grant from the Canadian Institutes of Health Research (CIHR; EOP-39322). R.J.O. was supported by a grant from the Canadian Institutes of Health Research (CIHR; 142650). The RNA Group is supported by grants from both the CIHR (PRG-80169) and the l'Universite de Sherbrooke. G.A.R. held a post-doctoral fellowship from the National Cancer Institute of Canada\Terry Fox Foundation. J.P.P. holds the Canada Research Chair in Genomics and Catalytic RNA. Funding to pay the Open Access publication charges for this article was provided by CIHR (EOP-39322).
###end p 68
###begin p 69
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 69
###begin title 70
REFERENCES
###end title 70
###begin article-title 71
Getting your Pax straight: Pax proteins in development and disease
###end article-title 71
###begin article-title 72
A PANorama of PAX genes in cancer and development
###end article-title 72
###begin article-title 73
The oncogenic potential of Pax genes
###end article-title 73
###begin article-title 74
Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis
###end article-title 74
###begin article-title 75
Pax-5/BSAP: regulator of specific gene expression and differentiation in B lymphocytes
###end article-title 75
###begin article-title 76
Fidelity and infidelity in commitment to B-lymphocyte lineage development
###end article-title 76
###begin article-title 77
The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP
###end article-title 77
###begin article-title 78
Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein
###end article-title 78
###begin article-title 79
Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
###end article-title 79
###begin article-title 80
B cell-specific activator protein prevents two activator factors from binding to the immunoglobulin J chain promoter until the antigen-driven stages of B cell development
###end article-title 80
###begin article-title 81
###xml 46 49 <span type="species:ncbi:8790">Emu</span>
Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma
###end article-title 81
###begin article-title 82
###xml 43 48 <span type="species:ncbi:9606">human</span>
Sequence analysis of 5'-flanking region of human pax-5 gene exon 1B
###end article-title 82
###begin article-title 83
###xml 69 90 <span type="species:ncbi:12475">hepatitis delta virus</span>
Development of ribozyme-based gene-inactivations; the example of the hepatitis delta virus ribozyme
###end article-title 83
###begin article-title 84
Activation of the interferon system by short-interfering RNAs
###end article-title 84
###begin article-title 85
Off-targeting and other non-specific effects of RNAi experiments in mammalian cells
###end article-title 85
###begin article-title 86
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 6 27 <span type="species:ncbi:12475">hepatitis delta virus</span>
Human hepatitis delta virus RNA subfragments contain an autocleavage activity
###end article-title 86
###begin article-title 87
Prospects for antiviral ribozymes and deoxyribozymes
###end article-title 87
###begin article-title 88
Target-dependent on/off switch increases ribozyme fidelity
###end article-title 88
###begin article-title 89
Functional characterization of the SOFA delta ribozyme
###end article-title 89
###begin article-title 90
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells
###end article-title 90
###begin article-title 91
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
###end article-title 91
###begin article-title 92
###xml 73 78 <span type="species:ncbi:9606">human</span>
Real-time RT-PCR analysis of mRNA decay: half-life of Beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines
###end article-title 92
###begin article-title 93
Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme
###end article-title 93
###begin article-title 94
RiboSubstrates: a web application addressing the cleavage specificities of ribozymes in designated genomes
###end article-title 94
###begin article-title 95
The BCR signalosome: where cell fate is decided
###end article-title 95
###begin article-title 96
The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system
###end article-title 96
###begin article-title 97
EBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B cells
###end article-title 97
###begin article-title 98
Prednisolone sodium succinate down-regulates BSAP/Pax5 and causes a growth arrest in the Nalm6 pre-B cell line
###end article-title 98
###begin article-title 99
Overexpression of BSAP/Pax-5 inhibits switching to IgA and enhances switching to IgE in the I.29 mu B cell line
###end article-title 99
###begin article-title 100
Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma
###end article-title 100
###begin article-title 101
The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line
###end article-title 101
###begin article-title 102
The role of BSAP in immunoglobulin isotype switching and B-cell proliferation
###end article-title 102
###begin article-title 103
BSAP (Pax5)-importin alpha 1 (Rch1) interaction identifies a nuclear localization sequence
###end article-title 103
###begin article-title 104
The Pax-5 gene is alternatively spliced during B-cell development
###end article-title 104
###begin article-title 105
Functional analyses of two alternative isoforms of the transcription factor Pax-5
###end article-title 105
###begin article-title 106
Identification of Pax5 target genes in early B cell differentiation
###end article-title 106
###begin article-title 107
Gene discovery by ribozyme and siRNA libraries
###end article-title 107
###begin article-title 108
Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments
###end article-title 108
###begin article-title 109
CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification
###end article-title 109
###begin article-title 110
Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex
###end article-title 110
###begin article-title 111
Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity
###end article-title 111
###begin article-title 112
Modeling T- and B-cell growth and differentiation
###end article-title 112
###begin article-title 113
A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation
###end article-title 113
###begin article-title 114
Deregulated expression of PAX5 in medulloblastoma
###end article-title 114
###begin article-title 115
Loss of p53 function through PAX-mediated transcriptional repression
###end article-title 115
###begin article-title 116
Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter
###end article-title 116
###begin article-title 117
Different isoforms of BSAP regulate expression of AID in normal and chronic lymphocytic leukemia B cells
###end article-title 117

